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1 Summary 
Regulatory T cells (Treg cells) play a crucial role in the immune system by 
controlling the establishment and maintenance of immune tolerance and 
homeostasis. Treg cells have been described to perform additional  
non-immunological functions beyond their classical functions in peripheral tissues. 
In this context, best examples are the specialized Treg cell population in visceral 
adipose tissue (VAT). The VAT-resident Treg cells gain the ability to control 
metabolic parameters. To further extent the concept of tissue-resident Treg cells, 
we aimed to analyze the phenotype and function of Treg cells in the liver tissue. 
We observed a significant accumulation of hepatic Treg cells in neonatal mice at 
around day 10 after birth. With progressive maturation of the mice the  
Treg frequency normalized. The neonatal hepatic Treg cells were highly proliferative 
as demonstrated by cell cycle measurements. Furthermore, the cells showed the 
characteristic Treg cell methylation pattern of the Foxp3 locus. The Treg cell 
accumulation in the neonatal liver occurred in an immature liver with strongly 
proliferating hepatocytes, a low-grad inflammatory signature and changes in key 
gene expression. 
Depletion of Treg cells with the associated loss of Treg-mediated immune control 
induced major changes in the liver, including increased expression of immune-
related genes and genes regulating the circadian clock such as Rev-Erb- or Per1. 
The circadian expression of approximately 400 genes in the liver was affected by 
the ablation of Treg cells.  
Our results indicate that Treg cells are important to secure the circadian rhythm of 
genes regulating the hepatic clock as well as clock-controlled genes. Furthermore, 
the presence of Treg cells is required for a normal expression of genes involved in 
liver metabolism, especially in the neonatal phase of the mice. Therefore, we 
propose that Treg cells do not only control the inflammatory state of the liver, but 
are also critical for the establishment and maintenance of liver homeostasis.  
 
 
Zusammenfassung 
2 
2 Zusammenfassung 
Regulatorische T-Zellen (Tregs) spielen eine wichtige Rolle im Immunsystem da sie 
für die Etablierung und Aufrechterhaltung der Immuntoleranz sowie der 
Immunhomöostase im Gewebe verantwortlich sind. Tregs können neben ihren 
klassischen Funktionen zusätzlich nicht-immunologische Funktionen in peripheren 
Geweben ausführen. Ein bekanntes Beispiel für gewebe-spezialisierte  
Treg Populationen sind die Tregs im viszeralen Fettgewebe. Diese Zellen haben die 
Fähigkeit metabolische Parameter im Fettgewebe zu steuern. Unser Ziel war es 
den Phänotyp sowie die Funktion von Tregs im Lebergewebe zu analysieren, um 
das Konzept der gewebe-spezialisierten Tregs weiter zu entwickeln. 
Wir beobachteten eine signifikante Anreicherung von Tregs in der Leber von 
neugeborenen 10 Tage alten Mäusen. Die Treg Frequenz in der Leber normalisierte 
sich mit fortschreitender Reifung der Mäuse. Zellzyklus-Messungen 
demonstrierten, dass die Tregs in der neonatalen Leber stark proliferierten. Des 
Weiteren zeigten die Zellen ein für Tregs charakteristisches Methylierungsmuster 
des Foxp3 Lokus auf. Die signifikante Anreicherung von Tregs erfolgte in einer 
unreifen, neonatalen Leber mit stark proliferierenden Hepatozyten, einer 
niedriggradigen Entzündungssignatur sowie einer veränderten Expression von 
Lebergenen. 
Depletion von Tregs induzierte eine starke Veränderung der Genexpression der 
Leber. Die Expressionen von Immun-Genen sowie Regulatoren der zirkadianen 
Uhr, wie zum Beispiel Rev-Erb- oder Per1, erhöhten sich stark durch den Verlust 
der Treg-vermittelnden Immunkontrolle. Die zirkadiane Expression von rund 400 
Lebergenen war durch den  Verlust von Tregs in der Leber beeinträchtigt. 
Unsere Ergebnisse deuten an, dass Tregs wichtig für die sichere Ausführung des 
zirkadianen Rhythmus von Lebergenen, welche die zirkadiane Uhr regulieren oder 
von der zirkadianen Uhr kontrolliert werden, sind. Des Weiteren sind Tregs 
erforderlich für eine ungestörte Expression von Genen des Leberstoffwechsels, 
besonders in der Leberentwicklung von neonatalen Mäusen. Basierend auf diesen 
Ergebnissen kommen wir zu dem Schluss, dass Tregs nicht nur den 
Entzündungszustand der Leber kontrollieren, sondern auch eine entscheidende 
Rolle in der Etablierung und Erhaltung der Leber-Homöostase spielen. 
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3 Introduction 
 
3.1 The immune system 
The mammalian immune system protects our body from diseases using layered 
defense mechanisms with increasing specificity, whereby different tissue, cellular 
and molecular components all work together. Besides pathogens like viruses, 
bacteria, fungi or parasites, the immune system is also challenged with damaged 
or cancerous cells of the host itself. Allergies, autoimmune diseases or infections 
with pathogens can result from impaired function of the immune system. The 
vertebrate immune system can be divided into two parts: the innate and the 
adaptive immune system (Murphy et al., 2008; Alberts et al. 2008). 
 
3.1.1 The innate immune response 
Innate immune responses serve as a first line of host defense in a non-specific 
manner. Three different mechanisms of the innate immune defense are involved in 
the clearance of infections before the adaptive immune systems needs to be called 
into play to work together to eliminate the pathogens (Alberts et al. 2008). Physical 
and chemical barriers build the first line of defense for pathogens. For example, 
skin and mucosal epithelia as well as the acidic pH of the stomach block access of 
microorganisms to the vertebrate host. The second mechanism of the innate 
immune defense involves cell-intrinsic responses. Cells such as neutrophils, 
macrophages or dendritic cells (DC) take up pathogens via phagocytosis und use 
different mechanisms to destroy pathogens. For example, engulfed pathogens are 
digested after fusion of the phagosome with the lysosome. The third mechanism of 
the innate immune defense includes a specialized set of phagocytic cells that 
helps to clear the body of pathogens and infected cells. Professional phagocytic 
cells recognize conserved structures expressed on the surface of pathogens 
through a complex and overlapping molecular network of pattern-recognition 
receptors (PRRs) (Alberts et al. 2008). Receptor ligation results in activation of 
complement cascades to opsonize the pathogen. Moreover, secretion of cytokines, 
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chemokines and co-stimulatory molecules leads to local inflammation and 
chemotactic attraction of further immune cells to site of inflammation (Akira, 
Uematsu, and Takeuchi 2006). Natural killer (NK) cells are involved in the 
destruction of infected cells by inducing apoptosis. When the innate immune 
response fails to clear or keep the infection at bay, the adaptive immune response 
comes into play and both work together to eliminate the infection. Nevertheless, 
the innate immune defense plays a critical role in controlling early infections 
because of the delayed activation of the adaptive immune defense (Alberts et al. 
2008).  
 
3.1.2 The adaptive immune response 
In comparison to the unspecific immune response mounted by the innate system, 
the adaptive immune response is pathogen-specific and provides long-lasting 
memory. While invading pathogens as well as their toxic product are destroyed by 
adaptive immune responses, several mechanisms are in place to avoid immune 
responses directed against self-molecules. Two different types of immune 
responses -antibody response and T cell-mediated immune response- can be 
distinguished, which are performed by different classes of lymphocytes (Alberts et 
al. 2008).  
During the antibody response, bone marrow-derived B cells become activated and 
secrete antibodies to opsonize pathogens (Alberts et al. 2008).   
In the T cell-mediated immune response naïve thymus-derived T cells, expressing 
either the surface co-receptor CD4 or CD8, circulate in the bloodstream and 
peripheral lymphoid organs until the cells recognize a specific antigen with their  
T cell receptor (TCR). Antigens are presented on the surface of antigen-presenting 
cells (APCs) by the major histocompatibility complex (MHC) (Alberts et al. 2008). 
Besides the binding to their specific antigen, T cells require distinct cytokine  
co-stimulation and CD28-dependent co-stimulation mediated by the binding to the 
APC surface proteins CD80 or CD86. T cell differentiation into different effector  
T cells subtypes depends on the kind of pathogen (Murphy, Travers, and Walport 
2008).  
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CD8+ T cells recognize a complex of MHC class I molecules and peptides from 
intra-cellular pathogens such as viruses (Alberts et al. 2008). Stimulated  
CD8+ T cells differentiate into cytotoxic T lymphocytes (CTLs), killing infected host 
cells by the release of cytotoxic granules such as granzymes or perforins (Jenkins 
and Griffiths 2010).  
CD4+ T cells recognize extra-cellular peptides presented by MHC class II 
molecules and differentiate upon stimulation into different CD4 effector subsets 
such as T helper 1 (TH1), TH2 and TH17 cells (Alberts et al. 2008, Murphy et al., 
2008). T helper cell subsets fulfill different functions to help regulating immune 
responses such as inducing B cell antibody class switch, helping to activate CTLs 
or maximizing bactericidal activity of macrophages (Alberts et al. 2008). The 
different subsets are characterized by different transcription factors and cytokine 
secretion patterns. The transcription factor T-bet and the secretion of  
Interleukin- (IL-) 2 and interferon (INF)- characterize the TH1 subset, which is 
induced through the cytokines IL-12 and INF-. IL-4 induce the differentiation of  
TH2 cells, characterized by the expression of the transcription factor GATA3 and 
the release of IL-4, IL-13 and IL-5 (Koch et al. 2009; Campbell and Koch 2011). 
The TH17 lineage is induced by exposure to the transforming growth factor 
(TGF-) and IL-6. TH17 cells express the transcription factor RORγT and secret  
IL-17 (Korn et al. 2009). 
The natural killer T (NKT) cells are another lymphocyte cell type, which is important 
for the adaptive immune response. Like the T helper cell subsets, the  
NK1.1+CD4+ cells develop in the thymus and carry a TCR consisting of one - and 
one -chain. Glycosphingolipid-activated NKT cells secret IFN- and IL-4, mobilize 
CD4 and CD8 T cell responses by activation of DCs, and activate NK cells as well 
as antibody production by B cells (Bendelac, Savage, and Teyton 2007). 
Regulatory T (Treg) cells, a subpopulation of CD4+ conventional T cells (Tconv cells), 
regulate both the innate and the adaptive immune responses to foreign and  
self-antigens and prevent autoimmunity (Hori, Takahashi, and Sakaguchi 2003; 
Fontenot, Gavin, and Rudensky 2003). Treg cells are in the focus of this thesis and 
will be explored in detail in the following chapters of this introduction. 
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3.2 Regulatory T cells 
Treg cells modulate both the innate and the adaptive immune responses to foreign 
and self-antigens and limit the extent of inflammation while also preventing 
autoimmunity. Thereby, Treg cells play a central role in the immune system by 
controlling the establishment and maintenance of immunologic tolerance and 
homeostasis (Feuerer, Hill, et al. 2009; Hori, Takahashi, and Sakaguchi 2003).  
Treg cells represent around 3 - 5% of the entire T cell pool and are characterized by 
high expression of the IL-2 receptor molecule  (CD25) and the lineage marker 
transcription factor forkhead box P3 (Foxp3) (Hori, Takahashi, and Sakaguchi 
2003; Fontenot, Gavin, and Rudensky 2003). It is now well established that 
deficiency or dysfunction of Treg cells, due to loss-of-function mutations in the 
Foxp3 gene, are responsible for various autoimmune diseases, allergies and other 
sometimes fatal immune disorders in mice and human. Scurfy mice, carrying a 
mutated Foxp3 gene, develop multi-organ autoimmunity and lymphoproliferation, 
which leads to the death of the mice by the age of 24 days (Brunkow et al. 2001; 
Godfrey et al. 1991). The counterpart in humans is the fatal immune dysregulation 
polyendocrinopathy enteropathy (IPEX) syndrome, which is developed in humans 
with an X-linked FOXP3 mutation (Bennett et al. 2001).  
Treg cells have conserved suppressive mechanisms to exert their 
immunosuppressive functions (Vignali, Collison, and Workman 2008). One 
mechanism of Treg-mediated suppression is the secretion of cytokines such as  
IL-10, IL-35 and TGF- which have inhibitory effects on Tconv cells. Another 
mechanism of Treg-mediated suppression is the induction of apoptosis in target 
cells in a granzyme A or B- and perforin-dependent manner (Grossman et al. 
2004; Gondek et al. 2005). The high expression of the surface receptor CD25 on 
Treg cells can also contribute to the Treg cell suppressive capacity by consuming 
local IL-2, which results in starving of other IL-2-dependent Tconv cells (Oberle et al. 
2007). Furthermore, the Treg-mediated direct transfer of the second messenger 
cyclic adenosine monophosphate (cAMP) into target cells and the generation of 
adenosine by the expression of the ectoenzymes CD39- and CD73 on the Treg cell 
surface result in Treg-mediated suppression of target cells (Vignali, Collison, and 
Workman 2008). To inhibit the activation of Tconv cells, Treg cells use different 
mechanism to suppress the Tconv-activating DCs. The CD4 homologue lymphocyte 
activation gene 3 (Lag3) interacts with MHC class II molecules on DCs to block 
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their maturation and thereby activation of Tconv cells (Liang et al. 2008). 
Furthermore, the surface molecule cytotoxic T lymphocyte associated protein 4 
(Ctla-4) on Treg cells is important for Treg-mediated suppression of DCs. 
Engagement of Ctla-4 with the surface receptors of the B7 family (CD80/CD86) on 
DCs leads to expression and release of the inhibitory enzyme indoleamine 2, 3-
dioxygenase (Ido) and results in suppression of Tconv cells (Mellor and Munn 2004).  
There are two different main pathways for the generation of Treg cells in vivo. The 
majority of functionally mature Foxp3+ Treg cells are produced in the thymus. The 
remaining part of the Treg cells is generated in the periphery, where naïve 
CD4+Foxp3- T cells develop into periphery-derived CD4+Foxp3+ Treg (pTreg) cells 
under certain conditions (Abbas et al. 2013). 
 
3.2.1 Thymic-derived Treg cells 
The majority of Treg cells is like all other types of T cells thymic-derived. The 
thymus establishes immune tolerance by eliminating potentially autoreactive  
T cells from the T cell pool as well as by generating the tolerance-mediating 
population of thymic (t)Treg cells (Hsieh, Lee, and Lio 2012; Josefowicz, Lu, and 
Rudensky 2012). T cells stem from the common lymphoid progenitors (CLPs), 
which in turn develop from pluripotent hematopoietic stem cells (HSCs) in the bone 
marrow. After migration to the thymus, CLPs give rise to thymocytes, which 
undergo highly controlled selection processes to differentiate into different types of 
mature T cells. Double negative (DN) thymocytes do neither express T cell 
receptors (TCRs) nor the surface co-receptors CD4 and CD8 (Miller 2011). 
Depending on their CD25 and CD44 expression DN cells are divided into four 
subsequent developmental stages (DN1-DN4). During these stages the first gene 
arrangement takes place to express TCR, TCRand TCR chains. Thereby, the 
cells commit their T cell lineage to either T cells or T cells. After TCRβ 
rearrangement, thymocytes committed to the T cell lineage start to express a 
pre-TCR complex, composed of the TCRβ chain, a pre-Tα molecule and the 
receptor CD3. These thymocytes differentiate into double-positive (DP) cells by  
co-expressing CD4 and CD8. DP cells start to rearrange their Tcra gene to 
express a surface  TCR on their surface. To further maturate into specialized 
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CD4 or CD8 single-positive cells, DP cells undergo positive and negative selection 
processes (Murphy et al., 2008). 
The interaction of high affinity TCRs with self-peptides presented by MHCs plays a 
central role in the generation of thymus-derived T cells. During positive selection,  
DP T cells recognize MHC class I or II molecules presented by cortical thymic 
epithelial cells (cTECs). Interaction of DP T cells with MHC class I molecules on 
the surface of cTECs leads to the development of single-positive CD8 T cells, 
whereas interaction with MHC class II molecules results in CD4 T cell lineage 
commitment. DP T cells, which fail to recognize MHC I or II molecules with their 
TCRs undergo apoptosis (Josefowicz, Lu, and Rudensky 2012; Taniuchi 2009). 
Negative selection helps to eliminate potentially autoreactive T cells. Medullary 
thymic epithelial cells (mTECs) and other thymic APCs present a broad range of  
self-peptide:MHC complexes towards the positively selected CD4+ or CD8+ T cells. 
mTECs are able to express a broad repertoire of mRNA transcripts encoding 
proteins characteristic of differentiated cell-types (Miller 2011), which is promoted 
by the transcription factor autoimmune regulator (AIRE). Positively selected  
CD4+ or CD8+ T cells with a strong interaction between their TCR and the  
self-peptid:MHC complex are driven into apoptosis to eliminate potentially 
autoreactive T cells. CD4+ or CD8+ T cells with low to moderate TCR affinity 
towards self-antigen survive this selection process (Josefowicz, Lu, and Rudensky 
2012; Klein et al. 2014). However, CD4+ T cells with a medium TCR affinity that 
lies between the signal strength required for positive selection and clonal deletion 
are able to escape deletion and differentiate into CD25+Foxp3-CD4+ tTreg cell 
precursors (Josefowicz, Lu, and Rudensky 2012). In addition, TCR stimulation 
leads to activation of the nuclear receptor 4a1 (Nr4a1). Experiments using a 
transgenic reporter mouse, which express the green fluorescent protein (GFP) 
under the control of the Nr4a1 promoter verified that differentiation into tTreg cells 
requires a higher signaling strength as compared to Tconv cells (Moran et al. 2011). 
However, the exact mechanism that leads to tTreg cell generation or clonal deletion 
of self-reactive T cells are still not well defined. 
Additionally to the TCR activation, costimulatory signals via CD28 play a central 
role in tTreg cell differentiation. CD28 deficiency results in a massive decrease in 
Treg cell frequency (Salomon et al. 2000). Furthermore, CD28 was shown to 
regulate tTreg cell development and function due to its central cell-intrinsic role in 
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the induction of Foxp3, Gitr and Ctla-4 in DP thymocytes (Tai et al. 2005; Campbell 
and Koch 2011). In addition to the TCR- and CD28-dependent tTreg cell 
differentiation, CD4+ thymocytes require IL-2 and IL-15 exposure to develop into 
mature CD25+Foxp3+CD4+ tTreg cells (Campbell and Koch 2011; Fontenot et al. 
2005). These common -chain cytokines, as well as other stimuli such as TGF-β 
activate the transcriptional machinery regulating Foxp3 gene expression. IL-2 and 
TGF-β stimulation as well as co-stimulation via CD28 is essential for tTreg 
differentiation but dispensable for Tconv cell development in the thymus (Fontenot et 
al. 2005). 
Several signaling pathways get activated downstream of TCR and CD28 signaling 
and lead to activation of distinct transcriptions factors such as NFκB, Ap-1 and 
Nfat. cRel, a transcription factor of the NFкB family seems to bind to the conserved 
non-coding sequence 3 (CNS3) promoter region and thereby initiates Foxp3 
expression (Zheng et al. 2010). Activation of the AKT-mTOR pathway has been 
described to have an inhibitory effect on Foxp3 expression (Haxhinasto, Mathis, 
and Benoist 2008). Furthermore, the Nr4a family members have been identified as 
critical transcription factors for the regulation of Foxp3 expression, since deficiency 
of Nr4a1, Nr4a2 and Nr4a3 leads to the complete loss of Foxp3 expression 
(Sekiya et al. 2013). 
The development of tTreg cells is generally delayed compared to Tconv cells during 
ontogeny in the thymus. It has been shown that around day 4 after birth, the 
CD25+ T cell percentage among total CD3+ T cells in the spleen increases. Day 3 
thymectomized mice show a reduced and delayed percentage of CD25+ T cells in 
the spleen in comparison to control mice (Asano et al. 1996). Furthermore, these 
thymectomized mice develop severe autoimmune diseases resulting from the 
selective reduction in Treg cells relative to self-reactive T cells, which can be 
inhibited by injection of peripheral Treg cells from adult mice (Suri-Payer et al. 1998; 
Itoh et al. 1999; Asano et al. 1996; Fontenot et al. 2005). In conclusion, Treg cells 
which start to migrate from the thymus into the periphery after day 3, are essential 
for inducing and maintaining self-tolerance.  
Recently, the important role of Aire in modulating the tTreg cell repertoire in the 
early life of mice has been described. A unique subpopulation of Aire-dependent 
perinatal tTreg cells has been identified, which play a critical role for the induction of 
immune self-tolerance (Yang et al. 2015). Aire is necessary during the neonatal 
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window to prevent the development of multi-organ autoimmunity and induce  
long-lasting tolerance (Guerau-de-Arellano et al. 2009). Treg cell depletion during 
the first 10 days after birth using the NOD.Foxp3-DTR system results in multi-
organ autoimmunity, which is normally typical for Aire-deficient mice on the NOD 
background. Mice depleted of Treg cells at a later time-point show no dramatic 
outcome (Yang et al. 2015). Moreover, through a tamoxifen inducible Treg cell 
lineage-tracer system using the NOD.Foxp3eGFP-Cre-ERT2xR26Y reporter 
mouse, it has been shown that neonatally generated and tagged Treg cells stably 
persist in adult mice and show distinct functional and phenotypic properties such 
as higher activation and proliferation capacities, increased expression of genes 
associated with Treg cell effector function, more suppressive properties as well as 
different T cell receptor repertoires (Yang et al. 2015). Treg cells generated in the 
neonatal age window play an important role in maintaining self-tolerance, since 
neonatal generated and tagged Treg cells are able to reserve the autoimmune 
phenotype after their injection in Aire-deficient mice. In contrast, prevention of the 
typical Aire autoimmune pathology cannot be achieved following transfer of 
thymus- or periphery-derived Treg cells from older mice. Thereby, this study 
demonstrate that Aire seems to be critical for the induction of a unique 
subpopulation of tTreg cells during the neonatal age period (Yang et al. 2015).  
 
3.2.2 Thymus-derived versus peripheral-induced Treg cells 
Following development in the thymus, Treg cells as well as Tconv cells enter the 
periphery to circulate through peripheral non-lymphoid tissues and secondary 
lymphoid tissues such as spleen and lymph nodes. A smaller part of the Treg cell 
population is generated in the periphery. Hereby, Foxp3-CD4+ Tconv cells can be 
stimulated with TGF-β and IL-2 and activated through specialized APCs to convert 
into pTreg cells. A phenomenon well described for gut and colon microenvironment 
(Yadav, Stephan, and Bluestone 2013; Lee, Bautista, and Hsieh 2011; Lathrop et 
al. 2011). While both pTreg and tTreg cells express similar levels of Foxp3, the two 
populations can be discriminate based on their expression of the transcription 
factor Helios of the Ikaros family and the cell surface transmembrane glycoprotein 
Neuropilin-1 (Nrp1; CD304) (Thornton et al. 2010; Yadav et al. 2012). Both Helios 
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and Nrp1 are dominantly expressed in tTreg cells and absent or reduced in  
pTreg cells (Yadav et al. 2012). Moreover, recent studies have described that 
during tTreg cell differentiation characteristic DNA demethylation patterns are 
induced upon TCR stimulation. tTreg cells feature a specific demethylation pattern 
in characteristic Treg cell signature genes such as Foxp3 (Ohkura et al. 2012). 
Demethylation of CpG islands in the CNS2 of the Foxp3 gene is essential to 
promote stable Foxp3 gene expression (Zheng et al. 2010). In vitro induced  
Treg (iTreg) cells and pTreg cells fail to demethylate the CNS2 region and eventually 
lose Foxp3 expression (Hori 2011). Therefore, the CNS2 region is termed  
Treg-specific demethylated region (TSDR). The analysis of the methylation status of 
the CNS2 region in the Foxp3 gene is another important marker to discriminate 
between tTreg cells, iTreg cells, pTreg cells as well as Tconv cells (Ohkura et al. 2012). 
 
3.2.3 Heterogeneity idea of Treg cell 
It is known that CD4+ Tconv cells develop into different T helper subsets depending 
on distinct cytokine signals the cells receive during activation. For example,  
TH1 cells develop in the presence of IFN-and IL-12, whereas IL-4 is necessary for 
TH2 cell differentiation (Campbell and Koch 2011). Treg cells also are a 
heterogeneous population. The first Treg cell subsets were identified in secondary 
lymphoid tissues such as spleen and lymph nodes (Feuerer et al. 2010; 
Josefowicz, Lu, and Rudensky 2012; Feuerer, Hill, et al. 2009). Genome wide 
transcriptional profiling and functional characterization studies identified that 
distinct Treg cell subsets in secondary lymphoid tissue can differ in the expression 
of transcription factors, such as T-bet, Gata3, Stat3 and Bcl6 that also have 
essential roles in the respective T helper subset (TH1, TH2, TH17 and follicular T 
helper cells (TFH)) (Fig. 1) (Josefowicz, Lu, and Rudensky 2012). It was shown that 
deletion of these transcription factors leads to impaired suppression of the 
respective Tconv cell subsets. For example, suppression of TH2 responses is 
disabled in Irf4- or Gata3-depleted Treg cells (Wohlfert et al. 2011; Zheng et al. 
2009). Therefore, the matched symmetry of expression patterns between Tconv cell 
subsets and Treg cell subsets expands and supports Treg cell functions.  
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Figure 1: Treg cell subsets. Functional Treg cell subsets are determined by expression of distinct 
transcriptions factors.  
 
The heterogeneous Treg cell subset idea has been extended by the introduction of 
a novel concept of tissue-resident Treg cells (Burzyn et al. 2013; Burzyn, Benoist, 
and Mathis 2013; Cipolletta et al. 2012; Feuerer, Herrero, et al. 2009). Distinct 
features make each of the tissue-resident Treg cells unique such as the expression 
of distinct chemokine receptors, effector molecules, transcription factors as well as 
TCR repertoires (Burzyn, Benoist, and Mathis 2013). Specialized tissue-resident 
Treg cell populations have been described in several non-lymphoid tissues like 
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adipose tissue, muscle, skin and lung (Burzyn et al. 2013; Cipolletta et al. 2012; 
Arpaia et al. 2015; Scharschmidt et al. 2015). In these peripheral tissues, Treg cells 
perform non-classical Treg cell functions like helping to control metabolic 
homeostasis in adipose tissue or inducing tissue repair in injured muscles (Burzyn 
et al. 2013; Arpaia et al. 2015; Cipolletta et al. 2012; Feuerer, Herrero, et al. 2009).  
 
3.2.4 Tissue-specialized Treg cells  
Visceral adipose tissue 
One of the well described examples of tissue-resident Treg cells is the Treg cell 
population in visceral adipose tissue (VAT). The Treg cell frequency in VAT is 
notably higher as compared to lymphoid tissue. VAT-resident Treg cells represent 
around 50% of the CD4+ T cell pool, whereas only up to 5 to 15% of the  
CD4+ T cell population in spleen and lymph node are Treg cells (Burzyn, Benoist, 
and Mathis 2013). Treg cell colonization in the visceral adipose tissue happens in 
the first weeks of life and is later independent of thymic input (Kolodin et al. 2015). 
It has been reported that in addition to the expression of classical Treg cell 
signature genes, Treg cells in the visceral adipose tissue differently express more 
than two thousand genes, leading to a unique functional Treg cell phenotype 
(Burzyn, Benoist, and Mathis 2013; Feuerer, Herrero, et al. 2009). For example, 
specific chemokine receptors such as CCR1, CCR2 and CCR9, as well as the 
immunomodulatory cytokine IL-10 are overexpressed in VAT-resident Treg cells. 
Another feature of VAT-resident Treg cells are the distinct TCR sequences, which 
show little overlap to their counterparts in lymphoid tissue (Feuerer, Herrero, et al. 
2009). VAT-resident Treg cells are able to take up fat droplets via the expression of 
CD36 and perform non-immunological functions such as controlling metabolic 
parameter in adipose tissue. (Feuerer et al. 2010; Cipolletta et al. 2012; Burzyn, 
Benoist, and Mathis 2013). Furthermore, these cells are able to modulate obesity-
associated insulin resistance, pro-inflammatory cytokine secretion as well as cell 
infiltration in visceral adipose tissue (Feuerer, Herrero, et al. 2009; Cipolletta et al. 
2012). The key driver of this VAT-resident Treg cell phenotype is the peroxisome 
proliferator-activated receptor- (PPAR-), which normally functions as a “master 
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regulator” of adipocyte differentiation (Feuerer, Herrero, et al. 2009; Cipolletta et al. 
2012). In vitro it has been shown that up-regulation of the VAT Treg cell signature is 
induced by interaction of PPAR-with Foxp3 (Feuerer, Herrero, et al. 2009; 
Cipolletta et al. 2012). Deficiency of PPAR- in Treg cells leads to a reduced 
number of Treg cells in visceral adipose tissue as well as to an under-
representation of the specific signature of VAT-resident Treg cells (Feuerer, 
Herrero, et al. 2009; Cipolletta et al. 2012). It is still not completely known how and 
where the specialized phenotype of VAT-resident Treg cells is generated. One 
could speculate that once Treg cells enter the visceral adipose tissue, a VAT-
specific gene expression prolife is induced which leads to a distinct Treg cell 
signature.  
 
Injured muscle tissue 
The introduction of Treg cells specialized in muscle-repair further extended the 
concept of tissue-resident Treg cells (Burzyn et al. 2013). Treg cells in healthy 
muscle tissue make up a small population of around 10% of the CD4+ T cell pool. 
Most of the studies describing the muscle-resident Treg cell phenotype and function 
are done under pathological conditions. Accumulation of lymphocytes in muscle 
tissue is known to occur in human Duchenne muscular dystrophy (DMB) patients 
(Tidball and Villalta 2010) and dystrophic muscles of dytrophin-deficient mice 
harboring a muscular dystrophy (mdx) mutation (Eghtesad et al. 2011). Dystrophic 
muscle of mdx mice and human DMB patient show an elevated percentage of 
activated Treg cells (Vetrone et al. 2009). Muscle-resident Treg cells have the 
function to modulate dystrophinopathy by controlling the balance between type 1 
and type 2 inflammatory responses. Osteopontin seems to regulate Treg cell 
number or stability since osteopontin-deficient mdx mice have elevated muscular 
Foxp3 mRNA level (Vetrone et al. 2009). Depletion of CD25-expressing cells in 
mdx mice increased inflammatory responses in the injured muscle combined with 
impaired muscle fiber regeneration (Burzyn et al. 2013). However, an elevated  
Treg cell frequency and IL-10 concentration are observed after treatment with  
IL-2/anti-IL-2 mAb complexes, which results in decreased myofiber injury (Villalta 
et al. 2014). Therefore, Treg cells play an important role in limiting muscle damage 
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by suppressing the development of type 1 inflammatory responses. 
Recently, Burzyn and colleagues describe that Treg cells rapidly accumulate in 
skeletal muscle after acute muscle injury induced via the administration of 
cardiotoxin (Burzyn et al. 2013). The Treg cell frequency increased to about  
50% of the entire T cell pool within seven weeks, long after local tissue 
inflammation has declined. Microarray-based-gene expression studies reveal that 
Treg cells in injured muscle tissue have a unique gene expression profile closely 
related to VAT-resident Treg cells with high expression levels of amphiregulin and 
IL-10 (Burzyn et al. 2013). Muscle Treg cells contribute to repair processes in 
injured muscles, since the epidermal growth factor receptor (EGF-R) ligand 
amphiregulin enhances the differentiation of muscle cell precursors as well as 
lowers the expression of proteins associated with fibrosis, (Burzyn et al. 2013). 
Collectively, Treg cells play a critical role once acute muscle damage has occurred 
by actively enhancing muscle repair. 
 
Virus-infected lung tissue 
The Treg cell population in virus infected-lung tissue is another example for 
specialized Treg cells in peripheral tissues that are able to adopt distinct effector 
mechanisms matching their target cells or tissues. In addition to the above 
described finding of amphiregulin-expressing Treg cells specialized in muscle-
repair, influenza-infected lungs harbor a Treg cell population that has an essential 
role in tissue protection, depending on their production of amphiregulin. Depletion 
of Treg cells leads to the loss of Treg-derived amphiregulin in influenza-infected 
lungs and therefore to an elevated level of acute lung damage with unaffected viral 
load and T cell responses (Arpaia et al. 2015).  
Treg cells act as a kind of universal monitor of mucosal barriers. Through the ability 
to rapidly respond to tissue damage and to retain lung structural and functional 
integrity during tissue damage, the cells are able to promote tolerance and tissue 
repair (Arpaia et al. 2015). 
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3.3 Liver cells 
The liver is one of the largest internal organ of the body. Besides the efficient 
metabolism of nutrients, digestion and detoxification, a further liver function is the 
maximization of immune surveillance (Jenne and Kubes 2013; Crispe 2003). 
Around 80% of the incoming blood arrives in the portal vein. The other 20% of the 
blood passing though the liver is coming from the hepatic artery. The hepatic 
sinusoid combines the two blood supplies and the blood is transported to the 
central vein between plates of hepatocytes through spaces that are lined by liver 
sinusoidal endothelium cells (LSECs) (Jenne and Kubes 2013; Crispe 2003). 
The permanent exposure to food and microbial products from the intestine leads to 
a tolerogenic state of the liver (Tiegs and Lohse 2010; Crispe 2003). Several 
mechanisms, including the expression of immunosuppressive cytokines and 
induction of Treg cells, mediate the induction and maintenance of tolerance in the 
liver. In the late 1960s, long-term acceptance of liver allografts without 
immunosuppression demonstrated the first time the tolerant feature of the liver 
(Edwards-Smith et al. 1996). 
Hepatocytes represent with around 80% of all liver cells the largest cell population 
in the liver. Studies have identified that hepatocytes as non-immune cells are 
capable of expressing innate immune receptors on their surface, leading to the 
induction of innate immune responses in the hepatocytes (Seki and Brenner 2008). 
With the production of acute-phase proteins and complement molecules, 
hepatocytes serve as a first line of defense against pathogens (Bode et al. 2012; 
Jenne and Kubes 2013; Crispe 2003). In addition, the expression of MHC I and II 
molecules on the surface of hepatocytes maximizes the capacity to activate 
lymphocytes, such as T cells (Warren et al. 2006; Crispe 2003; Jenne and Kubes 
2013).  
Kupffer cells are another major liver cell population. These cells are liver-resident 
macrophages and compromise about 35% of the non-parenchymal cells in the liver 
and around 80 - 90% of all tissue macrophages in the entire body (Crispe 2003). In 
contrast to typical macrophages, which are actively crawling through tissue to 
search for pathogens, Kupffer cells are located in the vasculature, adherent to 
LSECs, where they are directly exposed to blood and able to catch bacteria (Jenne 
and Kubes 2013). Kupffer cells act as APCs and detect and internalize pathogens 
through a set of surface receptors including scavenger receptors, Toll like 
Introduction 
17 
receptors (TLRs), complement receptors as well as antibody receptors (Jenne and 
Kubes 2013). Receptor signaling results in activation of Kupffer cells and 
production of cytokines and chemokines. Moreover, expression of MHC I, MHC II 
and costimulatory molecules on their surface contribute to activation and 
proliferation of T cells and NKT cells (Crispe 2003).  
Besides Kupffer cells and hepatocytes, the liver contains also a small population of 
hepatic stellate cells, which represent around 5 - 8% of the total liver cell pool 
(Jenne and Kubes 2013). These cells act in an APC-like manner through 
endocytosis of exogenous antigens and by expressing low amounts of molecules 
such as MHC I, MHC II, CD80 and CD86, which are required for antigen 
presentation to T cells (Vinas et al. 2003; Winau et al. 2007). Hepatic stellate cells 
are also able to induce cytokine production in T cells, NK cells and NKT cells. 
(Jenne and Kubes 2013). 
Approximately one third of all lymphocytes in the liver are NK cells (Jenne and 
Kubes 2013). NK cells respond to several cell-surface ligands on infected or 
damaged cells (Notas, Kisseleva, and Brenner 2009; Jenne and Kubes 2013).  
During liver damage NK cells seem to have a crucial role in T cell recruitment 
(Toyabe et al. 1997). Activated NK cells release perforin and granzyme as well as 
different cytokines. Secretion of IFN- results in induction of a multi-step 
cytokine/chemokine cascade to recruit T cells. Additionally, the liver contains an 
abundant number of NKT cells, expressing NK1.1 as well as the IL-2 receptor and 
an intermediate density of  TCRs (MacDonald 2002).  
Liver DCs are able to function as APCs and activate T cells. However, this function 
appears to be less efficient partly due to the local immunesuppressive cytokine 
milieu in the liver, including liver cell-secreted IL-10 (Sana et al. 2014). Contact of 
DCs with LSECs and hepatocytes further results in a reduced capacity of T cell 
activation. DC-derived IL-10 promotes a shift from TH1- to TH2-immune responses 
and the development of Treg cells (Bamboat et al. 2009). 
Around 50% of liver-resident lymphocytes express a TCR. In contrast to the 
CD4:CD8 ratio in the blood and lymphoid tissues, the liver is enriched with CD8+  
T cells (Jenne and Kubes 2013). Most of CD4 and CD8 T cells in the liver have an 
activated phenotype. They circulate through liver sinusoids and are able to interact 
with Kupffer cells and LSECs. Moreover, the liver contains one of the largest 
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accumulations of  T cells, representing around 15 - 25% of all hepatic T cells 
(Nemeth, Baird, and O'Farrelly 2009).  
Hepatic Treg cells have been extensively studied under pathological conditions. For 
example, a high Treg cell frequency among CD4+ T cells is observed in chronic 
Hepatitis C virus (HCV)-infected patients as well as in mice and patient suffering 
from hepatocellular cancer (HCC) and is often connected to a poor prognosis for 
the patients (Wang et al. 2016; Unitt et al. 2005). On the other side, autoimmune 
diseases such as autoimmune hepatitis (AIV) or primary biliary cirrhosis (PBC) 
show a reduction of Treg cell numbers (Lan et al. 2006; Ward et al. 2007; Erhardt et 
al. 2007). However, less is known about the function of Treg cells in a healthy liver. 
 
3.4 Circadian rhythm 
3.4.1 Circadian rhythm pathway 
Circadian rhythms are known as physiological processes occurring with a 
repeating period close to 24 hours (Duguay and Cermakian 2009; Scheiermann, 
Kunisaki, and Frenette 2013). It is hypothesized that circadian rhythms have been 
shaped in aerobic organisms to anticipate oxygen level changes in the 
environment induced by the solar magnetic activity cycle and phototrophic bacteria 
(Edgar et al. 2012; Scheiermann, Kunisaki, and Frenette 2013). Circadian rhythms 
ensure synchronization of internal physiology with external physiology to maintain 
homeostasis. Prokaryotes, fungi, algae, plants and mammals show physiological 
processes under circadian control (Scheiermann, Kunisaki, and Frenette 2013; 
Edgar et al. 2012).   
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In mammals up to 10% of the genome is under control of circadian rhythms, which 
are endogenously generated and maintained by the central clock located in the 
suprachiasmatic nucleus (SCN) of the hypothalamus (Arjona et al. 2012). There 
the central clock receives input from the retina and coordinates hormonal, 
biochemical and behavioral rhythms in other tissues to mediate their 
synchronization to external environment (Fig. 2) (Scheiermann, Kunisaki, and 
Frenette 2013; Ferrell and Chiang 2015). Daily light/dark cycles are the main 
Zeitgeber (german: “time giver”) inducing synchronization to a 24 hour rhythm 
(Fortier et al. 2011; Scheiermann, Kunisaki, and Frenette 2013).  
 
 
Figure 2: Circadian rhythm. Circadian rhythms are synchronized by `Zeitgeber´. These are 
external cues, such as light, synchronizing the endogenous rhythm to a 24-hour light–dark cycle. 
Light is processed via the retina and leads to the synchronization of rhythms in the master clock of 
the organism located in the hypothalamic suprachiasmatic nuclei (SCN). Peripheral clocks can be 
synchronized by the SCN central clock through humoral and neural output systems, but otherwise 
are able to oscillate autonomously by using the same molecular components (Scheiermann, 
Kunisaki, and Frenette 2013). 
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At the molecular level, the clock is controlled by auto-regulatory transcription-
translation feedback loops (Fig. 3). The core-clock genes circadian locomotor 
output cycles kaput (Clock) and brain and muscle Arnt-like 1 (Bmal1) build a 
heterodimer, which translocates into the nucleus and binds to canonical Enhancer 
box (E-box) promoter sequences of target genes to initiate circadian processes, 
including their own transcription (Ferrell and Chiang 2015; Scheiermann, Kunisaki, 
and Frenette 2013). Heterodimers of negative regulator genes, such as Period 1 
and 2 (Per1 and 2) or Cry1 and 2 (Cryptochrome1 and 2) translocate back to the 
nucleus to interact with Clock/Bmal1 to inhibit transcription. In the second auto-
regulatory transcription-translation feedback loop the activating nuclear retinoid-
related orphan receptor  (Ror) competes with the negative regulators Rev-Erb- 
and  for the binding to the Ror response element (Rore) binding site in the Bmal1 
promoter to activate or repress Bmal1 expression (Ferrell and Chiang 2015). In 
addition to these core-clock genes, many other genes are known to be under direct 
circadian control of the clock. These clock-controlled genes require important 
regulatory elements such as E-box and Rore sequences to drive their expression 
in a circadian manner (Partch, Green, and Takahashi 2014).  
Peripheral clocks are observed in various peripheral tissues, including the liver, 
lung, heart, pancreas, and white adipose tissue (Storch et al. 2002; Dibner and 
Schibler 2015; Haspel et al. 2014; Kohsaka et al. 2007). Even cultured primary 
cells can show periodic expression of core-clock genes (Molyneux et al. 2015). 
Although, peripheral clocks are known to be synchronized by the central clock, 
they are additionally able to oscillate autonomously by using the same molecular 
components. In the liver around 10% of genes are under circadian control, 
including genes involved in liver metabolisms such as regulation of glucose, lipid 
and nutrient homeostasis (Solt et al. 2012; Cho et al. 2012; Chaves et al. 2014; 
Yoshitane et al. 2014). 
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Figure 3: Molecular mechanisms of the circadian clock. Expression of the core-clock genes 
Clock (circadian locomotor output cycles kaput) and Bmal1 (brain and muscle ARNT-like 1) leads to 
the heterodimerization of Bmal1 and Clock in the cytoplasm. After the heterodimer translocated into 
the nucleus, it binds to canonical E-box sequences (CACGTG) in core-clock genes and  
clock-controlled genes to drive circadian processes and their own expression. Other core-clock 
genes, controlling the expression of the Clock/Bmal1 heterodimer are positive regulators, such as 
the retinoic acid receptor-related orphan receptor (Ror), which induce the expression of Bmal1 by 
binding to Ror response elements (Rores) in the Bmal1 promoter. Negative regulators such as  
Per (period circadian protein) and Cry (cryptochrome) build heterodimers and inhibit the binding of 
Bmal1/Clock to core-clock genes or clock-controlled genes. In a second autoregulatory feedback 
loop, the transcription of Rev-Erb-α and Rev-Erb-β is induced to inhibit Bmal1 transcription and 
competes with Ror for binding to Rores. This pathway stabilizes the clock, and can also directly 
drive circadian rhythms. After a period of time, the regulatory heterodimers are degraded and 
another transcription cycle is activated (Scheiermann, Kunisaki, and Frenette 2013). Other recently 
described negative regulators are Ciart and Bhlhb2. Ciart interacts with Bmal1 and represses 
Clock-Bmal1 activity in the nucleus, whereas Bhlhb2 is able to interact with Bmal1 and compete for 
E-box binding sites. 
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3.4.2 Lymphocytes and the circadian rhythm 
It has also been reported that immune cells have an intrinsic clock, which is 
important for certain functions such as migration, cytokine release and 
differentiation (Arjona and Sarkar 2006; Scheiermann, Kunisaki, and Frenette 
2013; Nguyen et al. 2013; Yu et al. 2013). For example, lymphocytes show 
different oscillation pattern over the day in the blood of humans and rodents 
(Depres-Brummer et al. 1997; Dimitrov et al. 2009). Furthermore, innate immune 
responses of NK cells as well as the cytokine release of macrophages in response 
of bacterial antigens are controlled by core-clock genes (Arjona and Sarkar 2006; 
Hayashi, Shimba, and Tezuka 2007; Keller et al. 2009).  
Although these data show that the immune cell’s intrinsic clock modifies their 
function, little is known about whether immune cells are able to control the 
circadian rhythm of other cells in peripheral organs such as the liver. 
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4 Aim of study 
To further extent the concept of specialized tissue-resident Treg cells, we aimed to 
analyze and characterize Treg cells and their function in the liver tissue. So far, only 
little is known about Treg cells in the liver environment under non-pathological 
conditions, particularly in neonatal mice at an age of 10 days. Therefore, on the 
one hand we were focusing on the functional characterization and development of 
hepatic Treg cells and on the other hand we wanted to examine if and how Treg cells 
influence the liver function. 
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5 Methods 
 
5.1 Mice 
5.1.1 Keeping 
Mice were 9 - 11 day-old or 5 - 7 week-old at the time of the experiments. All mice 
were cared for under the specific-pathogen free conditions in the animal facility of 
the DKFZ. All animal experiments were reviewed and approved by the 
governmental committee for animal experimentation in Karlsruhe, Germany.  
 
5.2 Tissue sample preparation 
5.2.1 Cell depletion  
Treg cells or macrophages were depleted by intraperitoneal injection of 40 ng/g 
body weight diphtheria toxin (DT) (Sigma) on two consecutive days (Fig. 4). For 
the 24 h time point single injection was used.  
 
 
 
 
 
Figure 4: Diphtheria toxin injection scheme. DT was injected into Foxp3-DTReGFP mice on two 
consecutive days. Afterwards the liver tissue was analyzed by performing flow cytometry, RNA 
microarray and proteomic analysis. 
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5.2.2 Tissue isolation and sample preparation 
For tissue isolation, mice were sacrificed and perfused with 10 ml of PBS by heart 
puncture.  Liver, spleen and lung were removed and mechanically dispersed.  
Liver suspension was digested for 30 min at 37°C in DMEM (Life Technologies) 
plus 1 mg/ml collagenase type IV (C5138, Sigma), 0.5% (w/v) BSA (Sigma) and  
20 μg/ml DNase I (Roche). Samples were enriched for liver T cells by 
centrifugation through a Percoll gradient (40 and 80% solutions; GE Healthcare). 
After centrifugation (20 min, 4°C, 1500 g, without break and acceleration) T cells 
were found between the two Percoll layers and washed with PBS. 
Ammonium chloride-potassium bicarbonate (ACK) lysis buffer was used to lyse 
erythrocytes in spleen and lung samples. 
 
5.2.3 AutoMACS cell purification 
For sorting of cells, liver and spleen samples were pre-purified with magnetic cell 
separation after digestion or ACK lysis treatment. Cells were labeled with  
CD45 microbeads (Miltenyi). Samples were subjected to positive selection for  
CD45+ cells on an autoMACS Pro Separator (Miltenyi) and subsequently stained 
for FACS sorting.  
For Kupffer cell analysis in the liver samples, cells were purified with magnetic 
beads after digestion. Cells were labeled with CD45 microbeads (Miltenyi) and 
isolated on an autoMACS Pro Separator (Miltenyi) system.  
 
5.2.4 Blood samples 
Blood was collected from sacrificed mice with heparin-coated syringes. Blood 
plasma was collected by centrifugation (10 min; 3 000 rpm). ALT and AST levels 
were measured by photometric analysis on the ADVIA 2400 system (Siemens 
Healthcare Diagnostics). Analysis was performed at the Zentrallabor, Medical 
Clinic-1, Analysezentrum, University Clinic Heidelberg. 
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5.3 Cell culture techniques 
5.3.1 Primary hepatocyte isolation 
Livers of anesthetized mice were perfused for 5 min with EGTA buffer  
(pH 7.2; 8 ml/min) following a 5 min perfusion with collagenase solution 
(collagenase type IV, Sigma; 1.2 mg/ml; 8ml/min) through the venae porta. Livers 
were extracted and liver capsule was carefully opened. Primary mouse 
hepatocytes were isolated and cultured in serum-free Williams’ Medium E. The 
viability of isolated hepatocytes was determined by trypan blue exclusion. Only cell 
preparations with a viability > 80% were used for experiments. The isolated cells 
were seeded in adhesion media on 6-well collagen type I-coated culture dishes at 
a density of 9x105 cells per well . Four hours after isolation, the primary 
hepatocytes were cultured in Williams Medium E supplemented with  
2 mM L-glutamine (Invitrogen) and 1% penicillin and streptomycin (Invitrogen). 
Different stimuli were added: dexamethasone (100 nM; Sigma), TNF-, IL-6, IL-10, 
TGF- or IFN- (50ng/ml; Peprotech). 
 
5.4 Flow cytometry  
For surface staining cells were labeled with antibodies for 30 min in FACS buffer at 
4°C. For intracellular Foxp3 and Helios staining, the intracellular Foxp3 staining 
buffer set (eBioscience) was used. Cells were treated with the fixation buffer for  
30 min at 4°C in the dark. Afterwards, the cells were intracellular stained with 
Fix/Perm buffer and the Foxp3 or Helios antibodies for 45 min at room temperature 
in the dark. Unstained or anti-CD4 single stained spleen cells  
(in the colors corresponding to the staining panel) were used for compensation. 
Cells were filtered and then analyzed using the BD Bioscience Canto II,  
LSR Fortessa or LSR II.  
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5.5 Fluorescence-activated cell sorting (FACS) 
For FACS-purification of cells the BD Biosciences FACSAria I, II or III instruments 
were used. After pre-purification with magnetic cell separation, surface of cells 
were stained (Fig. 5) and kept cold at 4 °C. After sorting, purity of cell sorts was 
controlled through post-sort analysis. Data were analyzed with Tree Star FlowJo 
(Treestar). 
 
Figure 5: Treg cell sorting scheme. Foxp3+CD25+CD4+TCRb+ Treg cells were purified out of liver 
and spleen of 10 day-old (10 d) and 6 week-old (6w) Foxp3-DTReGFP mice. 
 
5.5.1 In vivo proliferation assay 
We used two methods for analysis of the in vivo proliferative activity of the Treg 
cells or hepatocytes. First, we analyzed DNA-contents with Hoechst 33342  
(Life Technologies) and determined cell cycle indices (G2-M+S/G1-G0). Second, we 
i.v. injected EdU (5-ethynyl-2′-deoxyuridine), dissolved in sterile PBS at a dose of  
1 mg per mouse, to analyze quantified incorporation of nucleotides  
(Click-iT EdU Alexa Fluor 488 Flow cytometry Assay Kit (Life Technologies)). Mice 
were analyzed 4 hours after injection by flow cytometry as recommended by the 
manufacturer. 
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5.6 Epigenetics 
5.6.1 Purification and bisulfite conversion of genomic DNA  
CG methylation analysis with the 454 pyrosequencing technology was performed 
in the Division of Epigenetics of the DKFZ in Heidelberg by Dr. Achim Breiling. 
To analyze specific demethylation of the Treg-specific demethylated region (TSDR), 
we isolated Treg cells and Tconv cells from Foxp3-DTReGFP mice via FACS. DNA of 
indicated sorted cell populations was purified according to manufacturer’s 
guidelines using the DNEasy Blood and Tissue kit (Quiagen). DNA purity and 
concentration was measured via a NanoDrop® photometer and DNA concentration 
was adjusted to 2000 ng DNA. Bisulfite-conversion was performed using the 
EpiTect Bisulfite Conversion Kit (Quiagen). The Bisulfite Primer Seeker Software 
(http://www.zymoresearch.com/tools/bisulfite-primer-seeker) was used to calculate 
primer sequences based on manufacturers recommendations. To generate PCR 
amplicons from bisulfite-converted DNA we used barcode-labeled primers. PCR 
amplicons were separated from primer dimers on a 1 - 2% agarose gel. The 
amplicons were purified using a Quick Gel Extraction Kit (Life Technologies) and 
afterwards processes on a GS Junior Sequencer (Roche). Sequence reads were 
aligned to the BS-converted mouse genome. The methylation levels were 
visualized in heat maps. 
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5.7 Proteomics 
Quantitative differential proteomics experiments were performed in the Genome 
Biology Unit of the EMBL in Heidelberg by Sophia Föhr and Dr. Jeroen Krijgsveld. 
5.7.1 Protein digestion, labeling of peptides with stable isotopes 
(TMT) and fractionation 
Tissues from 10 day-old and 6 week-old livers were isolated 48 hours after Treg cell 
depletion with DT or PBS treatment. Mouse liver tissue (around 20 mg) was 
dissected, washed three times with ice cold PBS and subsequently grounded in a  
1 ml douncer. The slurry was washed again with ice cold PBS. The supernatant 
was sonicated in a Covaris S220 (430s, 17W). Extracted proteins were reduced 
and alkylated with 5 mM DTT and 10 mM iodoacetamide. Subsequently around 10 
mg portions were digested with LysC according to SP3 protocol (Hughes et al. 
2014).  Resulting peptides of replicates were pooled and labeled with TMT 10plex 
according to the manufacturer’s protocol. The labels 126, 127N, 127C, 128N, 
128C, 129N, 129C, 130N, 130C and 131 were mixed 1:1:1:1:1:1:1:1:1:1 based on 
peptide ratio and fractionated into 10 peptide fractions by high-pH reversed-phase 
chromatography (Sieber et al. 2016).  
 
5.7.2 LC-ESI-MS/MS analysis 
Peptides were separated using a nanoACQUITY UPLC system (Waters) fitted with 
a trapping column (nanoAcquity Symmetry C18; 5 μm (average particle diameter);  
180 μm (inner diameter) × 20 mm (length)) and an analytical column (nanoAcquity 
BEH C18; 1.7 μm (average particle diameter); 75 μm (inner diameter) × 200 mm 
(length)). Peptides were separated on a 120-minute gradient and were analyzed 
by electrospray ionization–tandem mass spectrometry using an Orbitrap Fusion 
(Thermo Fisher Scientific). Using a multi-notch approach (McAlister et al. 2014) the 
10 most-abundant ions from each MS1 scan were fragmented by collision-induced 
dissociation to generate an MS2 spectrum. Following each MS2 spectrum, an MS3 
spectrum was acquired as described (McAlister et al. 2014), in which multiple MS2 
fragment ions were selected in the MS3 precursor population using isolation 
Methods 
30 
waveforms with multiple frequency notches, using high energy collision-induced 
dissociation (HCD) and analysis in the Orbitrap. 
 
5.7.3 Protein identification and quantification 
MS raw data files were processed with ProteomeDiscoverer (version 1.4.) using 
Mascot (version 2.2.07) as the search engine against the Uniprot mouse database. 
Cysteine carbamidomethylation and methionine oxidation were set as fixed and 
variable modifications, respectively, and specifying digestion with LysC and 
quantification with TMT 10plex. A 1% false-discovery rate was required both at the 
peptide and protein level. 
 
 
5.8 PCR techniques 
5.8.1 RNA isolation and cDNA synthesis 
RNA was extracted using the RNeasy Microarray Tissue Mini Kit (Qiagen) or the 
innuPREP RNA Mini Kit (analytic jena). For the RNeasy Microarray Tissue Mini Kit 
liver and lung tissues (10 mg) were mechanically dispersed in 1 ml of TRIzol or 
QIAzol Lysis Reagent according to manufacturer’s instructions and frozen at -80°C 
until further processing 
For total RNA extraction of livers from Mdr2-/- mice peqGOLD RNAPure  
(Peqlab Biotechnologie, Erlangen, Germany) was used according to the 
manufacturer’s instructions.  
Sorted hepatic Foxp3+CD25+TCRb+CD4+ Treg cells, NK1.1+ NK cells, F4/80+ 
Kupffer cells and Ly6Chigh monocytes were FACS purified and RNA was extracted 
using the RNeasy Plus Micro Kit (Qiagen). 
For cDNA synthesis, the SuperScript reverse transcriptase (Invitrogen) and 
oligo(dT) primers were used according to manufacturer’s instructions.  
 
Methods 
31 
5.8.2 Quantitative real-time PCR 
For transcript quantification cDNA samples were analyzed by quantitative real-time 
PCR using the Power SYBR Green master mix (Life technologies) and the ViiA7 
instrument (Life technologies). Primer sequences are listed below. All qPCR 
primers were tested by serial dilutions, melting curve analysis and efficiency 
testing. Transcripts levels of target genes ('gene X') were quantified relative to the 
abundance of Hprt by the change-in-threshold (CT) method: 
relative expression = 2^ - (CT (gene X) - CT(Hprt)) 
 
 
5.8.3 RNA expression profiling 
The DKFZ Genomics and Proteomics Core Facility amplified and hybridized 
material to the Illumina MouseWG-6 v2.0 Expression BeadChip containing a total 
of 46,238 probes. Microarray scanning was done using an iScan array scanner. 
Data extraction was done for all beads individually, and outliers were removed 
when the absolute difference to the median was greater than 2.5 times MAD  
(2.5 Hampelís method). All remaining bead level data points were than quantile 
normalized. 
 
5.9 Bioinformatic and statistical analysis 
5.9.1 Bioinformatic and statistical analysis of proteomic data 
Quantitative differential proteomics experiments were performed in the Genome 
Biology Unit of the EMBL in Heidelberg by Sophia Föhr and Dr. Jeroen Krijgsveld. 
For the protein quantification only peptides were considered with summed reporter 
ion intensity greater than 10000 and with a value in at least two of four replicates, 
used as an input for the limma package in R/Bioconductor to calculate the adjusted  
P value.  Proteins with an adjusted P value lower than 0.05 were considered to be 
differentially expressed between the treatment and age of the mouse liver.  
Methods 
32 
5.9.2 Bioinformatics and statistical analysis of microarray data 
Bioinformatic analysis of microarray data were performed in the Division of 
Biostatistics of the DKFZ in Heidelberg by Thomas Hielscher. 
Gene expression data sets of DT and PBS treated livers and lungs of 10 day-old 
and 6 week-old Foxp3-DTReGFP mice were analyzed. Unspecific filtering was 
applied keeping only probes with at least one normalized expression value 
exceeding 100 in any of the samples. Normalized expression values were log2 
transformed. Circadian probes in PBS samples were identified with the 
JTK_CYCLE algorithm (Hughes, Hogenesch, and Kornacker 2010) using false 
discovery rates (FDR) of 5% and 20% as cut-offs.  Phase and amplitude estimates 
were used to fit a sinusoidal model for illustration. In a second approach, the RAIN 
algorithm (Thaben and Westermark 2014) was applied with a FDR cut-off of 1%. 
Unlike JTK, RAIN is able to additionally detect non-symmetrical wave pattern such 
as saw-tooth type rhythms.   
Differentially expressed probes between PBS and DT groups were identified using 
the empirical Bayes approach based on moderated t/F-statistics as implemented in 
the Bioconductor package limma (Ritchie et al. 2015). All P values in limma were 
adjusted for multiple testing using Benjamini-Hochberg correction in order to 
control the FDR. Probes with an FDR <5% were considered statistically significant. 
A model with factors group and time point was fitted and the group factor was 
tested for all probes. Fisher’s exact test was used to test for enrichment of 
circadian probes among probes being differentially expressed in DT samples. For 
the final list of regulated circadian probes, an interaction term between group and 
time was added to allow for detecting time-dependent differences/shifts between 
groups and an F-test on group and group-time interaction coefficients was 
performed.  
Samples from different organs (liver and lung) and mice of different age  
(6 week-old and 10 day-old) were assessed at a single time point for regulation 
due to Treg cell depletion (DT). In each subgroup a model with only group effect 
was fitted. The number of differentially expressed probes was subsequently 
compared between subgroups using a Chi2-test for proportions.  
Kolmogorov-Smirnov test was used to compare distribution of phase estimates 
between significantly and non-significantly regulated circadian probes.  
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Pearson’s correlation coefficient was used to find probes showing a similar  
DT-PBS regulation pattern over time as Per1 and Rev-Erb-. Here, the mean log2 
expression was calculated at each measured time point for DT and PBS samples 
separately, and the difference between group means at each time point was used 
as time-series of regulation. Goeman’s global test was used to compare 
expression of CYP family genes between age conditions.  
All analyses were performed using statistical software. RAIN was used as 
implemented in Bioconductor package rain. R v3.2. JTK_CYCLE software was 
downloaded from http://openwetware.org/wiki/HughesLab:JTK_Cycle.   
 
5.9.3 General statistical analysis 
Prism software (GraphPad) was used for statistical analysis of experimental data. 
Results were considered statistically significant with P values less than 0.05 and 
statistical tests and corresponding parameters are mentioned in the respective 
figure legends. 
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6 Materials 
 
6.1 Mice 
Mice were obtained from Charles River Breeding Laboratories (Wilmington, MA) or 
the Jackson Laboratory (Bar Harbor, ME) and housed under specific pathogen-
free conditions in the German Cancer Research Center animal facility: 
- Wild-type C57BL/6 mice 
- Nr4a1-eGFP (B6-Tg(Nr4a1-eGFP/cre)820Khog/J; Jackson stock no.: 
016617) 
- Csf1r-DTR mice (B6-Tg(Csf1r-HBEGF/mCherry)1Mnz x Lyz2tm1(cre)Ifo) 
(Schreiber et al. 2013)  
Mice bred and housed under specific pathogen-free conditions in the German 
Cancer Research Center animal facility: 
- Foxp3-DTReGFP mice (B6N.129(Cg)-Foxp3tm3Ayr; Jackson stock no.: 
016958) 
- Rag2-deficient mice (B6-Rag2tm1Fwa) (Shinkai et al. 1992) 
- Tlr4-deficient mice (B6.Tlr4lps-del/JthJ) (Poltorak et al. 1998) 
- Trif-deficient mice (B6.CgTicam1tm1Aki) (Ermolaeva et al. 2008) 
- MyD88-deficient mice (B6.Cg Myd88tm1Aki) (Adachi et al. 1998) 
- Mdr2-deficient mice (129-Abcb4tm1Bor) (Mauad et al. 1994) 
All animal experiments were approved by the Regierungspräsidium (Karlsruhe, 
Germany). 
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6.2 Antibodies 
Table 1: List of antibodies 
Antigen Clone Isotype Company 
CD11a M17/4 Rat IgG2a k BioLegend 
CD11b M1/70 Rat IgG2a k BioLegend 
CD11c N418 
Arm. Hamster 
IgG 
BioLegend 
CD19 145-2C11 Rat IgG2a k BioLegend 
CD25 PC61 Rat IgG1l BioLegend 
CD3 145-2C11 
Arm. Hamster 
IgG 
BioLegend 
CD4 RM4-5 Rat IgG2a k BioLegend 
CD43 1b11 Rat IgG2a k BioLegend 
CD44 IM7 Rat IgG2a k BioLegend 
CD45 30-F11 Rat IgG2a k BioLegend 
F4/80  BM8 Rat IgG2a k BioLegend 
Foxp3 FJK-16s Rat IgG2a k eBioscience 
Foxp3 MF-14 Rat IgG2a k BioLegend 
Helios 22F6 
Arm. Hamster 
IgG 
BioLegend 
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Ly6C HK1.4 Rat IgG2a k BioLegend 
Ly6G 1A8 Rat IgG2a k BioLegend 
NK1.1 PK136 Mouse IgG2 k BioLegend 
Nrp1 N43-7 Rat IgG2a k BioLegend 
Pcbd1 #PA5-26121 Rabbit / IgG  
Thermo Fisher 
Scientific 
TCRb H57-597 
Arm. Hamster 
IgG 
BioLegend 
 
 
6.3 Cytokines 
Table 2: List of cytokines 
Stimuli Company 
IL-6 recombinant murine Pepro Tech 
IL-10 recombinant murine Pepro Tech 
TGF recombinant human Pepro Tech 
TNF recombinant murine Pepro Tech 
IFN recombinant murine Pepro Tech 
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6.4 Kits 
Table 3: List of Kits 
Kit Company 
RNeasy Microarray Tissue Mini Kit  Qiagen 
innuPREP RNA Mini Kit  Analytic Jena 
peqGOLD RNAPure  Peqlab Biotechnologie 
RNeasy Plus Micro Kit Qiagen 
SuperScript reverse transcriptase  Invitrogen 
DNEasy Blood and Tissue kit  Quiagen 
EpiTect Bisulfite Conversion Kit  Quiagen 
Quick Gel Extraction Kit  Life Technologies 
intracellular Foxp3 staining buffer set  eBioscience 
Click-iT EdU Alexa Fluor 488 Flow 
cytometry Assay Kit  
Life Technologies 
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6.5 Bisulfite Primer 
Table 4: List of Bisulfite Primer 
Sample   Primer sequence 
Liver 
Treg 10d 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGTATATCTGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGTATATCAAAAAACAAATAATCTACCCCACAA 
Liver 
Tconv 10d 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGCCACGCTGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGCCACGCAAAAAACAAATAATCTACCCCACAA 
Spleen 
Treg 10d 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGATTATATGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGATTATAAAAAAACAAATAATCTACCCCACAA 
Spleen 
Tconv 10d 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGTCCGTCTGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGTCCGTCAAAAAACAAATAATCTACCCCACAA 
Liver 
Treg 6w 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGATGTCATGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGATGTCAAAAAAACAAATAATCTACCCCACAA 
Liver 
Tconv 6w 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGGCTACCTGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGGCTACCAAAAAACAAATAATCTACCCCACAA 
Spleen 
Treg 6w 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGACTCTCTGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGACTCTCAAAAAACAAATAATCTACCCCACAA 
Spleen 
Tconv 6w 
  
ForP CGTATCGCCTCCCTCGCGCCATCAGCGTACGTGGGTTTTTTTGGTATTTAAGAAAG 
RevP CTATGCGCCTTGCCAGCCCGCTCAGCGTACGAAAAAACAAATAATCTACCCCACAA 
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6.6 Quantitative real-time PCR primer 
Table 5: List of Sybr Primer 
Gene  For Primer Rev Primer 
Atf3 GAGGATTTTGCTAACCTGACACC TTGACGGTAACTGACTCCAGC 
Bhlhb2 ACGGAGACCTGTCAGGGATG GGCAGTTTGTAAGTTTCCTTGC 
Ccl2 AGGTCCCTGTCATGCTTCTG GCTGCTGGTGATCCTCTTGT 
Ccl4 ATGAAGCTCTGCGTGTCTG GAAACAGCAGGAAGTGGGAG 
Ccl5 CTGCTGCTTTGCCTACCTCT CCCACTTCTTCTCTGGGTTG 
Ccr2 CCTTGGGAATGAGTAACTGTGTGAT ATGGAGAGATACCTTCGGAACTTCT 
Ciart CCCTTCTGATAACGAGAGGGA TGAGGTGCTGTATGTTGGTTACT 
Cxcl10 CTCATCCTGCTGGGTCTGAG TCTTTTTCATCGTGGCAATG 
Dbp CATTCCAGGCCATGAGACTT TGGCTGCTTCATTGTTCTTG 
Foxo3 CTGGGGGAACCTGTCCTATG TCATTCTGAACGCGCATGAAG 
Hprt CTTTGCTGACCTGCTGGATT TATGTCCCCCGTTGACTGAT 
Ifng CAGCAACAGCAAGGCGAAA CTGGACCTGTGGGTTGTTGAC 
Il10 ATCGATTTCTCCCCTGTGAA TGTCAAATTCATTCATGGCCT 
Il15 TGCAATGAACTGCTTTCTCC TCTCCTCCAGCTCCTCACAT 
Il18 ACAACTTTGGCCGACTTCAC AGAGAGGGTCACAGCCAGTC 
Il1b AGTTGACGGACCCCAAAAG CTTCTCCACAGCCACAATGA 
Mki67 ATCATTGACCGCTCCTTTAGGT GCTCGCCTTGATGGTTCCT 
Per1 TGAAGCAAGACCGGGAGAG CACACACGCCGTCACATCA 
Per2 GAAAGCTGTCACCACCATAGAA AACTCGCACTTCCTTTTCAGG 
Rev-Erb-a TACATTGGCTCTAGTGGCTCC CAGTAGGTGATGGTGGGAAGTA 
Rev-Erb-b TGAACGCAGGAGGTGTGATTG TGAACGCAGGAGGTGTGATTG 
Tfgb GGAGAGCCCTGGATACCAA AGGGTCCCAGACAGAAGTTG 
Tnfa CCACCACGCTCTTCTGTCTAC AGGGTCTGGGCCATAGAACT 
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6.7 Reagents 
Table 6: List of Reagents 
Reagent/Kit Company 
ACK lysis buffer Lonza 
Albumin Fraction V Roth 
autoMACS Running Buffer Miltenyi Biotec 
Anti-Biotin Micro-Beads Miltenyi Biotec  
Bovine Serum Albumin Sigma 
Chloroform  Carl Roth 
Collagenase IV Sigma 
Deoxyribonucleotide Triphosphates 
(dNTPs) 
Life Technologies  
Dexamethasone Sigma 
Diphtheria Toxin From Corynebacterium Sigma 
DMSO Genaxxon Bioscience 
DNase I  Roche 
Dulbecco's Phosphate Buffered Saline 
(PBS) 
Sigma-Aldrich 
Ethanol 99,8%   Roth 
Fetal Calf Serum (FCS) (Cat. No. A15-
101, Lot No. A10109-2802) 
PAA Laboratories  
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Foxp3 / Transcription Factor Staining 
Buffer Set 
eBioscience 
GlycoBlue Life Technologies  
Heparin 5000U/ml Biochrom 
HEPES Solution PAA Laboratories  
Hoechst 33342 trihydrochlorid trihydrate Life Technologies 
L-glutamine Invitrogen 
Nuclease free sterile water  Biomol 
Oligo(dT) primers Life Technologies 
Penicillin Invitrogen 
Percoll GE Healthcare 
RNAse Inhibitor Genaxxon Bioscience 
streptomycin Invitrogen 
Superscript 2 Life Technologies 
Sybr Green Power Master Mix Life Technologies  
TRIzol Life Technologies  
Trypan Blue Biochrom 
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6.8 Plastic ware and consumables 
Table 7: List of Plastic ware and consumables 
Product Company 
Cell culture plates flat bottom 6, 24, 96 well  PAA 
Cell culture plates round bottom 96 well PAA 
Cell strainer 40µm BD Falcon 
Conical tubes 15 ml Nerbe Plus 
collagen type I-coated culture dishes 6 well Becton Dickinson 
Conical tubes 50 ml Greiner GBO 
Nitex nylon filter  SEFAR 
Pipette filter tips 1-200, 100-1000 µl StarLab 
Pipette tips 0.1-10, 1-200, 100-1000 µl StarLab 
Reaction tubes 1.5 ml Steinbrenner Laborsysteme 
Reaction tube safe-lock Eppendorf 
Syringe Luer-Lok 3 ml BD 
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6.9 Buffers and solutions 
Table 8: List of buffers and solutions 
Buffer/Solution Composition 
ACK Lysis Buffer 
PBS, 0.15 M NH4Cl, 10 mM KHCO3, 
0.1 mM Na2-EDTA 
stored at RT, pH 7.3, sterile filtrated  
Adhesion medium 
Williams E medium phenol red-free 
10% FCS 
100 nM Dexamethasone 
1% penicillin/streptomycin 
2 mM L-glutamine 
Fresh prepared 
Complete Medium 
DMEM, 10% (v/v) FCS, 10 mM HEPES,100 
U/ml Penicillin, 100 µg/ml Streptomycin, 1 
mM Pyruvate 
stored at 4°C 
EGTA Buffer 
475 mg EGTA 
Add ddH20 to 10 ml 
add NaOH for dissolving 
adjust pH 7.6 (HCL) 
sterile filter and stored at 4°C 
FACS buffer 
PBS, 0.1% (w/v) NaN3, 1% (v/v) FCS 
stored at 4°C, pH 7.4 
PBS 
Water, 0.27 mM KCl, 13.7 mM NaCl, 10 mM 
Na2HPO4, 0.2 mM KH2PO4 
stored at RT, pH 7.4, autoclaved 
Primary Hepatocyte culture medium 
Williams E medium phenol red-free 
1% penicillin/streptomycin 
2 mM L-glutamine 
stored at 4°C 
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6.10  Equipment 
Table 9: List of equipment 
Equipment Manufacturer 
AutoMACS Pro Separator Miltenyi Biotec  
Cell Culture Hood Safe 2020 Thermo fisher scientific 
Cell Culture Incubator, Galaxy 170 S Eppendorf  
Centrifuge 5415 R, 5424 and 5810 R Eppendorf  
FACSAria I, II and III BD Biosciences 
FACSCanto II, LSR II, LSRFortessa BD Biosciences 
Freezer (-20°C, -80°C) Liebherr and Thermo Fisher Scientific 
Fridge (4°C) Liebherr 
Mastercycler Pro S Eppendorf 
Nanodrop 2000 Thermo Fisher Scientific 
Neubauer Counting Chamber Karl Hecht 
pH Meter Sartorius 
Thermoblock Neoblock 1 Neolab 
UV gel documentation system Herolab 
ViiA 7 Real-Time PCR System Life Technologies 
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6.11 Software 
Table 10: List of software used for analysis 
Software Company 
Adobe Illustrator Adobe System 
EndNote Thomson Reuters 
FACS DIVA BD Biosciences 
FlowJo Treestar / Thermo Fisher 
ImageJ 64 ImageJ freeware 
Microsoft Office Microsoft 
Graphpad Prism Graphpad 
Viia 7 software Applied Biosystems 
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7 Results 
 
7.1 Hepatic regulatory T cells 
Increased Treg cell frequency in neonatal liver tissue 
Treg cell development is well described for the thymus of neonatal mice (Dujardin et 
al. 2004; Fontenot et al. 2005). Hepatic Treg cells have been extensively studied 
under disease conditions such as autoimmune hepatitis or primary biliary cirrhosis, 
though less is known about the physiological function of Treg cells in the liver, 
especially during neonatal development.  
To study neonatal Treg cells in the liver and lung tissue via flow cytometry, we used 
Foxp3eGFP reporter mice and co-stained for intracellular Foxp3 expression after 
careful exclusion of circulating Treg cells from liver and lung of 10 day-old and  
6 week-old mice (Fig. 6). Around 10 days after birth neonatal mice showed an 
increase in Treg cell frequency as well as total number of Treg cells per gram of liver 
tissue as compared to 6 week-old mice (Fig. 6a; Fig. 7a, b).  Interestingly, this 
difference was not observed in the spleen and only slightly seen in the lung of the 
same mice (Fig. 6; Fig. 7a). The percentage of CD4+ T cells was lower in the liver 
and spleen of neonatal mice as compared to adult mice, which was not observed 
in the neonatal lung (Fig. 6). 
A Foxp3 expression kinetic revealed that the hepatic Treg cell frequency peaked 
with around 30% of CD4+ T cells at day 10 and declined to less than 10% of  
CD4+ T cells during maturation of the mice which was not observed in the spleen 
or lung of the same mice (Fig. 7c, d).  
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Figure 6: Treg cell gating strategy in liver, spleen and lung. Flow cytometry analysis of 
Foxp3GFP+Foxp3+CD4+TCRb+ Treg cells from (a) liver, (b) spleen or (c) lung of about 10 day-old  
(10 d) and 6 week-old (6 w) Foxp3eGFP mice. 
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Figure 7: Treg cells in liver, spleen and lung of neonatal mice. Treg cells from about 10 day-old  
(10 d) Foxp3eGFP mice were compared to 6 week-old (6 w) Foxp3eGFP mice. (a) Quantification of 
Foxp3+ Treg cells in liver, spleen and lung. (b) Total numbers of Foxp3+ Treg cells per gram liver.  
(c) Kinetic of Foxp3+ Treg cell accumulation in liver and spleen. (d) Kinetic of Foxp3+ Treg cell 
accumulation in lung and spleen. Symbols represent individual animals and P values represent 
comparisons between 10 d and 6 w mice using ordinary two-way ANOVA with Sidak´s multiple 
comparison test (a) or Wilcoxon Test (b). NS, not significant; *P < 0.05 and ****P < 0.00005. 
 
To further characterize the origin of these Treg cells in the neonatal liver, we stained 
for the transcription factor Helios and the cell surface transmembrane glycoprotein 
Nrp1, both markers for thymus-derived Treg cells. Treg cells in the neonatal liver 
expressed Helios as well as Nrp1 (Fig. 8a - d). However, a slight increase in Helios 
expression as well as a decrease in Nrp1 expression was observed in hepatic  
Treg cells at the neonatal stage as compared to 6 week-old mice (Fig. 8b, d). 
Another way to identify stable Foxp3 expressing Treg cells is to analyze the DNA 
CpG methylation status of the Treg-specific demethylation region (TSDR) located in 
the conserved non-coding region 2 (CNS2) of the Foxp3 gene (Floess et al. 2007)  
(Fig. 8e). The epigenetic analysis revealed a demethylated TSDR in Treg cells from 
the neonatal and adult liver as well as the spleen (Fig. 8f). Therefore, Helios and 
Nrp1 expression as well as the DNA methylation status confirmed that hepatic Treg 
cells from neonatal mice were bona-fide thymus-derived Treg cells (Fig. 8f).  
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Figure 8: Hepatic Treg cells in neonatal mice are thymus-derived. Treg cells from about 10 day-
old (10 d) Foxp3eGFP mice were compared to 6 week-old (6 w) Foxp3eGFP mice.  
(a) Representative flow cytometry gating and (b) quantification of Helios+Foxp3+CD4+TCRb+ Treg 
cells in liver and spleen. (c) Representative flow cytometry gating and (d) quantification of 
Nrp1+Foxp3+CD4+TCRb+ Treg cells in liver and spleen. (e) Schematic figure of the Foxp3 gene with 
high CG-dinucleotide content highlighted in orange in the enhancer (ENH), promoter (PRO) and the 
Treg-specific demethylated region (TSDR) in the conserved-non-coding sequences 2 (CNS2).  
(f) Bisulfite sequencing of 6 CpGs in the TSDR region of the CNS2 in the Foxp3 gene of sorted 
Foxp3+CD4+ Treg cells and Foxp3-CD4+ Tconv cells from liver and spleen; yellow: demethylated CpG; 
blue: methylated CpG. Symbols represent individual animals and P values represent comparisons 
between 10 d and 6 w mice using ordinary two-way ANOVA with Sidak´s multiple comparison test 
(b, d); NS, not significant; **P < 0.005, ***P < 0.0005. 
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To exclude the possibility that the increased accumulation of Treg cells in the liver 
of neonatal mice was C57BL/6 background-specific, we analyzed Foxp3+ T cells in 
mice carrying the non-obese diabetic (NOD) background (Fig. 9). NOD mice 
spontaneously develop Type 1 diabetes at the age of around 10 weeks. We 
analyzed the mice before the development of the disease to test whether the  
Treg cell frequencies were different in neonatal NOD mice. As seen previously in 
the liver of Foxp3eGFP C57BL/6 mice (Fig. 6; Fig. 7), the Treg cell frequency in the 
neonatal liver of NOD mice was significantly increased as compared to 6 week-old 
NOD mice (Fig. 9a, b). This difference was not observed in the spleen of the same 
mice (Fig. 9a, b). Based on our findings, we suggest that accumulation of  
Foxp3+ T cells in neonatal mice is mouse strain-independent. 
 
 
Figure 9: Hepatic Treg cells in neonatal NOD mice. Treg cells from about 10 day-old (10 d) NOD 
mice were compared to 6 week-old (6 w) NOD mice. (a) Representative flow cytometry gating of 
Foxp3+CD4+TCRb+ Treg cells in liver and spleen. (b) Quantification of Foxp3+CD4+TCRb+ Treg cells 
in liver and spleen. Symbols represent individual animals and P values represent comparisons 
between 10 d and 6 w mice using ordinary two-way ANOVA with Sidak´s multiple comparison test. 
NS, not significant; *P < 0.05. 
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For further characterization of the hepatic Treg cells in the liver of neonatal mice we 
studied CD44 and CD11a expression. CD44 is a transmembrane glycoprotein 
involved in T cell activation and memory (Dutton, Bradley, and Swain 1998; Baaten 
et al. 2010). We observed that generally around 70 - 80% of Foxp3+ Treg cells in 
the liver and around 40 - 60% of Foxp3+ Treg cells in the lung and spleen expressed 
CD44 (Fig. 10a - c). At the neonatal stage, the liver, lung and spleen showed an 
increase of activated CD44+Foxp3+ Treg cells as compared to the same organs in 
adult mice. The neonatal liver contained with around 80% of CD44+ Treg cells a 
larger antigen-experienced and activated Treg cell population as the lung and the 
spleen of the same mice (Fig. 10a, c). 
The lymphocyte function-associated antigen 1 (CD11a; LFAT) is expressed on 
activated T cells and has been implicated in mediating the homing of T cells to 
lymphoid and non-lymphoid tissue (Koboziev et al. 2012), as well as function as a 
co-stimulatory molecule for T cell activation (Kandula and Abraham 2004; 
Koboziev et al. 2012). In general, we observed a higher CD11a expression on 
hepatic T cells in comparison to splenic T cells (Fig. 11a, b). Around 70% of  
Treg cells in the neonatal liver and 40% of Treg cells in the adult liver expressed 
CD11a (Fig. 11a).  
Taken together, our findings indicate that the accumulation of thymus-derived  
Treg cells in 10 day-old mice is liver-specific and that these cells show characteristic 
high expression levels of the activation marker CD44 and the adhesion molecule 
CD11a.  
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Figure 10: CD44 surface expression of Treg and Tconv cells in liver, spleen and lung. 
Representative histograms of CD44+Foxp3+CD4+TCRb+ Treg cells (R1, right panel) and  
CD44+Foxp3-CD4+TCRb+ Tconv cells (R1, middle panel) from (a) liver, (b) spleen or (c) lung of  
10 day-old (10 d; red line) and 6 week-old (6 w, black line) Foxp3eGFP mice.  
(a - c; left panel) Quantification of CD44+Foxp3+CD4+TCRb+ Treg cells and CD44+Foxp3-
CD4+TCRb+ Tconv cells in liver, spleen and lung. Symbols represent individual animals and P values 
represent comparisons between 10 d and 6 w mice using ordinary two-way ANOVA with Sidak´s 
multiple comparison test (a - c). **P < 0.005, ***P < 0.0005. 
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Figure 11: CD11a+ Treg and Tconv cells in liver and spleen. (a - b) Treg cells from about 10 day-old  
(10 d) C57BL/6 mice were compared to 6 week-old (6 w) C57BL/6 mice. Representative dot plots 
(upper panel) and quantification (lower panel) of CD11a+Foxp3+CD4+TCRb+ Treg cells and 
CD11a+Foxp3-CD4+TCRb+ Tconv cells in (a) liver and (b) spleen. Symbols represent individual 
animals and P values represent comparisons between 10 d and 6 w mice using ordinary two-way 
ANOVA with Sidak´s multiple comparison test. NS, not significant; *P < 0.05, ****P < 0.00005. 
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Proliferation activity of hepatic Treg cells 
To test whether the hepatic Treg cell accumulation in neonatal liver tissue is based 
on local proliferation, we measured the proliferative activity of T cell populations in 
neonatal and adult mice. We observed that Treg cells in tissues of neonatal mice 
seemed to be generally more proliferative than Tconv cells or Treg cells in the adult 
liver based on two different assays: a cell-cycle state assessment using the DNA-
intercalating dye Hoechst 33342 (Fig. 12) and a rapid nucleotide-incorporation 
assay using the thymidine analog EdU (Fig. 13a, b). In addition, hepatic Treg cells 
from neonatal mice were also more proliferative than their counterparts in spleen 
and lung (Fig. 12d, Fig. 13b). EdU incorporation assay revealed that about 16% of 
the Treg cells in the neonatal liver were in cycle which was substantially higher than 
the 8% of proliferating Treg cells found in the neonatal spleen (Fig. 13b). 
Next, we determined whether the in situ proliferation of Treg cells from the neonatal 
liver was induced by antigen-specific TCR activation. Nur77-eGFP reporter mice 
have been described to highlight TCR activation by Nr4a1 (Nur77)-induced GFP 
expression without detecting cytokine-driven activation of T cells (Moran et al. 
2011). Analyzing these reporter mice, we observed a significantly higher 
percentage of Nr4a1+ Treg cells in 10 day-old livers as compared to 6 week-old 
livers. Consequently, the Treg cell proliferation in the liver tissue of neonatal mice 
seems to be due to an antigen-specific TCR-driven proliferation (Fig. 13c, d). 
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Figure 12: Proliferative activity of T cell populations in liver, lung and spleen measured by 
flow cytometry staining with Hoechst 33342-A. (a - c) Representative histograms of 
Foxp3+CD4+TCRb+ Treg cells and Foxp3-CD4+TCRb+ Tconv cells showing percent cells in the  
G1-G0 (left), S (middle) and G2-M (right) phases of the cell cycle from about 10 day-old (10 d) and  
6 week-old (6 w) Foxp3eGFP mice. (d) Quantification of cell-cycle indices calculated as  
((S + G2-M) / G1-G0) and presented in arbitrary units (AU). Symbols represent individual animals 
and P values represent comparisons between 10 d and 6 w mice using ordinary two-way ANOVA 
with Sidak´s multiple comparison test (d). NS, not significant; **P < 0.005, ***P < 0.0005,  
****P < 0.00005. 
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Figure 13: Proliferative activity and TCR stimulation of hepatic Treg cells. (a) Representative 
dot plots and (b) quantification of EdU+ cells of Foxp3+ Treg cells (black) and Foxp3- Tconv cells (blue) 
from liver, lung and spleen of about 10 day-old (10 d) and 6 week-old (6 w) Foxp3eGFP mice.  
(c) Flow cytometry gating and (d) quantification of Nr4a1highFoxp3+ Treg cells from the liver of 10 
day-old (10 d) and 6 week-old (6 w) Nur77-eGFP mice. Symbols represent individual animals and P 
values represent comparisons between 10 d and 6 w old mice using ordinary two-way ANOVA with 
Sidak´s multiple comparison test (b) or unpaired t test with Welch-correction (d). NS, not significant; 
*P < 0.05, **P < 0.005, and ****P < 0.00005. 
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Gene expression analysis of hepatic Treg cells 
Gene expression studies using a RNA-based microarray platform helped us to 
further characterize the proliferating neonatal wave of hepatic Treg cells. We 
detected about 100 two-fold differentially expressed genes in hepatic Treg cells 
from 10 day-old mice in comparison to their counterparts in adult livers (Fig. 14a). 
While expression of the Treg cell characteristic transcription factor Foxp3 was 
similar in 10 day-old and 6 week-old hepatic Treg cells, one of the strongest 
differentially expressed genes was Interleukin 10 (Il10) (Fig. 14a). In comparison to 
Treg cells from the adult liver or the neonatal spleen, Il10 was highly over-
expressed in Treg cells from the neonatal liver (Fig. 14a, b, c). More differences 
were found in the expression of survival- (Birc5 (Survivin); Ier3),  
co-stimulation- (Tnfrsf9) or chemotactic migration- (Cxcr3) related genes  
(Fig. 14a). Additionally, the serum glycoprotein Alpha2-HS (Ahsg), synthesized by 
hepatocytes, and the natural killer cell protein 7 (Nkg7), which has been described 
to be under control of Foxp3 (Sugimoto et al. 2006), were highly up-regulated in 
Treg cells from the neonatal liver in comparison to Treg cells from the adult liver or 
the neonatal spleen (Fig. 14a, b). The over-expression of these genes was specific 
for Treg cells from the neonatal liver, since neither the comparison to Treg cells from 
the adult liver nor the comparison to Treg cells from the neonatal spleen revealed 
the same expression level (Fig. 14a, b, c).  
Analysis using the Gene Ontology (GO) platform showed that several clusters of 
over-expressed genes in the 10 day-old hepatic Treg cells were involved in 
metabolic processes as well as DNA replication (Fig. 14d). The significantly 
increased expression pattern of ligase Lig1, several members of the DNA helicase 
complex (Mcm2, 5, 7), endonuclease Fen1 and DNA topoisomerase Top2a in  
10 day-old hepatic Treg cells, further supported the increased proliferative potential 
of these cells (Fig. 14e).  
Collectively, our results reveal a distinct phase during the neonatal liver 
development with an elevated accumulation of proliferating thymus-derived  
Treg cells over-expressing distinct genes such as Il10. 
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Figure 14: Gene expression analysis of hepatic Treg cells. RNA microarray analysis of sorted T 
cells from 10 day-old (10 d) and 6 week-old mice. (a) Fold change (FC) to P value plot of hepatic 
Foxp3+CD4+ Treg cells from 10 d and 6 w mice. (b) Fold change to P value plot of hepatic versus 
splenic Foxp3+CD4+ Treg cells from 10 d mice. Significantly up-regulated genes of the comparison 
hepatic 10 d versus 6 w Treg cells from (a) are highlighted in red in both (a) and (b). (c) Il10 gene 
expression in Foxp3+ Treg cells and Foxp3- Tconv cells from liver (black) and spleen (grey) in 10 d 
and 6 w mice, presented in arbitrary units (AU). (d) Gene ontology analysis of the top 150 
significantly up-regulated genes of the comparison of 10 d versus 6 w hepatic Treg cells represented 
with their P values per process. (e) Gene expression of Lig1, Mcm5, Mcm2, Fen1, Mcm7, Top2a in  
Foxp3+ Treg cells of 10 d and 6 w mice, presented in AU. Symbols represent individual animals (c) 
and P values represent comparisons between 10 d versus 6 w mice using paired t test (c), 
PANTHER over-representation test (d) or unpaired t test with Welch-correction (e). *P < 0.05 and 
**P < 0.005. 
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7.2 The neonatal liver 
The liver microenvironment in neonatal mice 
Since high Treg cell frequencies are usually associated with some kind of 
inflammation, we decided to explore the liver microenvironment during the time the 
neonatal wave of proliferating hepatic Treg cells occurred using quantitative  
real-time PCR. We detected an around two-fold increase in the expression levels 
of pro- and anti-inflammatory cytokines such as Tnfa, Tgfb and Il1b in the neonatal 
liver (Fig. 15a). Additionally, elevated expression levels of distinct chemokine 
ligands (Ccl) such as Ccl2, Ccl4 and Ccl5 were observed (Fig. 15b, c).  
 
Figure 15: Gene expression in neonatal and adult livers. Quantitative real-time PCR analysis of 
whole liver mRNA for (a) cytokines (Tnfa, Tgfb, Ifng, Il1b, Il15, Il10), (b) the chemokine receptor 
Ccr2 and (c) chemokines (Ccl2, Ccl4, Ccl5, Cxcl10) in 10 day-old (10 d) and 6 week-old (6 w) 
Foxp3eGFP mice. Symbols represent individual animals and P values represent comparisons 
between 10 d and 6 w mice using unpaired t test with Welch-correction calculated with log2 values. 
NS, not significant, *P < 0.05 and **P < 0.005. 
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To determine whether immune cells other than Treg cells also accumulate in the 
neonatal liver compartment, we analyzed the frequency of hepatic macrophages, 
monocytes and NK cells (Fig. 16, left and middle panels). Neonatal mice showed 
no increased accumulation of hepatic NK cells, macrophages or monocytes  
(Fig. 16 left and middle panels). Instead, we detected a significantly higher 
percentage of F4/80+ Kupffer cells and Ly6Clow monocytes in the liver of  
6 week-old mice compared to 10 day-old mice (Fig. 16b, c; middle panels). 
Interestingly, the neonatal liver revealed a F4/80-CD11b+ population which was not 
detectable in the adult liver (Fig. 16b, left panel, black gate). After sorting of  
NK1.1+ NK cells, F4/80+ Kupffer cells and Ly6Chigh monocytes we analyzed once 
the expression levels of Ifng or Tnfa (Fig. 16, right panels). Hepatic  
NK1.1+ NK cells from neonatal mice seemed to express a slightly increased level 
of Ifng compared to 6 week-old mice. Moreover, we observed an up-regulated 
level of Tnfa in F4/80+ Kupffer cells as well as hepatic Ly6Chigh monocytes in these 
neonatal mice (Fig. 16b, c, right panels).  
Overall, by analyzing the frequencies of different, but not all, immune cell subsets, 
Treg cells appear to be the only cells that accumulate in the neonatal liver. 
However, the up-regulated expression of Ifng and Tnfa by NK and myeloid cells 
may correlate with the measured increased expression levels of these cytokines in 
the liver of neonatal mice (Fig. 15).  
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Figure 16: NK cells, macrophages and monocytes in the neonatal liver. Analysis of hepatic  
NK cells, F4/80+ macrophages and monocytes in 10 day-old (10 d) and 6 week-old (6 w) mice.  
(a) Representative dot plot (left panel) and quantification (middle panel) of sorted hepatic  
NK1.1+ cells. Quantitative real-time PCR analysis (right panel) for Ifng of sorted hepatic and splenic 
NK1.1+ cells. (b) Representative dot plot (left panel) and quantification (middle panel) of sorted 
hepatic F4/80+ macrophages (red gate) and monocytes (blue and black gates). Quantitative real-
time PCR analysis (right panel) for Tnfa of sorted hepatic or splenic F4/80+ macrophages  
(red gate). (c) Representative dot plot (left panel) and quantification (middle panel) of Ly6chigh  
(blue gate) and Ly6clow monocytes (black gate), pre-gated on F4/80lowCD11b+ cells (blue gate in b, 
left panel). Quantitative real-time PCR analysis (right panel) for Tnfa of sorted hepatic or splenic  
Ly6chigh monocytes (blue gate). For quantitative real-time PCR analysis, RNA was isolated from 
pooled cells out of about 5 - 8 mice. Symbols represent individual animals and P values represent 
comparisons between 10 d and 6 w mice using unpaired t test with Welch-correction (a, b) and 
ordinary two-way ANOVA with Sidak´s multiple comparison test (c). NS, not significant, *P < 0.05 
and ***P < 0.0005.  
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To determine whether hepatocytes are the main producer of the increased 
cytokine and chemokine levels in the neonatal liver, we performed quantitative 
real-time PCR analysis with primary hepatocytes isolated from neonatal and adult 
livers. The expression levels of the cytokines Tnfa and Il1b were significantly 
increased in primary hepatocytes from neonatal mice (Fig. 17), as seen before in 
the quantitative real-time PCR analysis of whole liver RNA (Fig. 15a). These 
findings support the assumption that mainly hepatocytes are responsible for the 
increased secretion of cytokines and chemokines in the neonatal liver.  
 
 
Figure 17: Gene expression in neonatal and adult primary hepatocytes. Quantitative real-time 
PCR analysis of Il1b and Tnfa in isolated primary hepatocytes (PH) of 10 day-old (10 d) and  
6 week-old (6 w) mice. Symbols represent individual animals and P values represent comparisons 
between 10 d versus 6 w mice using unpaired t test with Welch-correction calculated with log2 
values.**P < 0.005. 
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It is known that the gut-liver axis plays a critical role in modulating the hepatic 
immune system since the liver receives blood via the portal vein from the gut 
(Crispe 2003). We determined whether bacterial antigen could trigger the 
accumulation of hepatic Treg cells and the characteristic inflammatory liver gene-
signature by analyzing neonatal mice deficient for receptor molecules or adapter 
molecules of the Toll-like-receptor (TLR) pathways (Fig. 18a, b, c, d).  Interestingly, 
neonatal mice deficient for Tlr4 or the TLR adapter molecules Trif and MyD88 
showed the same accumulation of hepatic Treg cells as previously observed in  
10 day-old Foxp3eGFP mice (Fig. 18a; Fig. 7a). Therefore, our results indicate a 
limited effect of bacterial antigens or bacterial products on the Treg cell 
accumulation in the neonatal liver. Furthermore, the increased gene expression 
levels of the cellular proliferation marker Mki67 (Fig. 18b) as well as Ccl2 and Tgfb 
(Fig. 18c, d) in the neonatal liver of Tlr4-/- and Trif-/- mice indicated the same 
inflammatory milieu and a high proliferative activity of liver cells as observed before 
in Foxp3eGFP mice. 
Another reason for the increased level of hepatic cytokines and chemokines in the  
10 day-old mice could be the first settlement of lymphocytes in the neonatal liver 
tissue, since T cell seeding of peripheral organs continues during the neonatal 
period (Garcia et al. 2000). However, analysis of liver tissue isolated from neonatal  
Rag2-deficient mice, which lack mature B and T cells, showed the same 
characteristic inflammatory liver gene-signature detected before in Foxp3eGFP 
mice (Fig. 18e). Therefore, we assume that neonatal tissue seeding by T cells and 
B cells is not the cause for the characteristic low-grade inflammatory signature in 
the neonatal liver. 
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Figure 18: Hepatic gene expression in MyD88-/-, Trif-/-, Tlr4-/- and Rag2-/- mice. (a) Quantification 
of Foxp3+ Treg cells in 10 day-old (10 d) and 6 week-old (6 w) Tlr4-/-, MyD88-/- and Trif-/- mice 
assessed by flow cytometry. (b - d) Quantitative real-time PCR analysis of whole liver mRNA for  
(b) Mki67, (c) cytokines and (d) chemokines in 10 d and 6 w Tlr4-/-, MyD88-/- and Trif-/- mice.  
(e) Quantitative real-time PCR analysis of whole liver mRNA for cytokines and chemokines in 10 d 
and 6 w Rag2-/- mice. Symbols represent individual animals and P values represent comparisons 
between 10 d and 6 w mice using ordinary two-way ANOVA with Sidak´s multiple comparison  
test (a) calculated with log2 values (b - d) and unpaired t test with Welch-correction calculated with 
log2 values (e). NS, not significant, *P < 0.05, **P < 0.005, ***P < 0.0005 and ****P < 0.00005. 
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Assuming liver-intrinsic reasons for the accumulation of Treg cells and the 
characteristic low-grade inflammatory signature in the neonatal liver, we performed 
microarray analysis to study differences between neonatal and adult livers. We 
identified about 1700 differentially expressed gene probes. Among those, we 
detected some expected differences such as alpha-fetoprotein (Afp), produced in 
the liver during fetal development (Fig. 19a). Other differences, such as the 
increased expression of genes from the S100 family indicated tissue-stress and 
inflammation in the liver of 10 day-old mice, whereas the reduced gene expression 
of members of the aldehyde dehydrogenase (Aldh) family, the cytochrome P450 
(Cyp) family and the major urinary family (Mup) family demonstrated the functional 
immaturity of the neonatal liver (Fig. 19a). Interestingly, almost all genes from the 
Cyp family were under-represented in the neonatal liver (Fig. 19b), which was not 
observed in other peripheral organs such as the lung (Fig. 19c). Quantitative 
proteomic analysis by mass spectrometry revealed the same decreased protein 
expression of Cyp family members in the neonatal liver in comparison to the adult 
liver (Fig. 19d, Appendix Table 11). Additionally, the neonatal liver showed under-
represented gene expression of members of the Mup family, which was not 
observed in the lung of the same mice, as Mup proteins are known to be primarily 
made in the liver and secreted through the kidneys into the urine (Fig.19e, f).  
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Figure 19: The neonatal liver. (a) Hepatic RNA-based microarray analysis: significantly >2-fold 
differentially expressed genes are highlighted in 6 week-old (6 w) mice (right panel, blue) and  
10 day-old (10 d) mice (right panel, red) with indicated genes (left panel). (b) Hepatic RNA-based 
microarray analysis of 10 d and 6 w mice with highlighted gene expression of the Cyp family.  
(c) Lung RNA-based microarray analysis of 10 d and 6 w mice with highlighted gene expression of 
the Cyp family. (d) Quantitative mass spectrometry analysis of Cyp protein expression in  
10 d mice compared to 6 w mice presented in log2 ratios. (e - f) RNA-based microarray analysis  
of (e) liver and (f) lung in 10 d and 6 w mice with highlighted gene expression of the Mup family.  
P values represent comparisons between 10 d versus 6 w mice using the Goemans Global Test (a) 
and the Chi-squared test (b, d, e, f), NS = not significant. 
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Analysis using the Gene Ontology (GO) platform revealed that many of the  
two-fold up-regulated genes in the liver of 10 day-old mice were involved in 
processes of cell cycle and cell division regulation (Fig. 20a). We therefore tested 
the proliferative activity of primary hepatocytes from neonatal livers. Staining with 
Hoechst 33342 and quantitative real-time PCR for the proliferation marker Mki67 
revealed increased proliferation by primary hepatocytes in the neonatal mice 
compared to the adult mice (Fig. 20b, c).   
In summary, we detected a proliferating and expanding liver environment in 
addition to the functional immaturity of the neonatal liver, the elevated 
inflammatory liver microenvironment and the high number of proliferating Treg cells. 
 
 
Figure 20: Proliferative activity in neonatal primary hepatocytes. (a) Gene ontology (GO) 
analysis of the > 2-fold significantly up-regulated genes in neonatal livers, detected by RNA-based 
microarray analysis of 10 d versus 6 w livers and represented with their P values per process.  
(b) Proliferative activity of Pcbd1+ primary hepatocytes measured by flow cytometry staining with 
Hoechst 33342-A. Representative histograms of Pcbd1+ hepatocytes showing percent cells in the 
G1-G0 (left), S (middle) and G2-M (right) phases of the cell cycle (left panel) from about 10 day-old 
(10 d) and 6 week-old (6 w) Foxp3eGFP mice (left panel); quantification of cell-cycle indices 
calculated as ((S + G2-M) / G1-G0) and presented in arbitrary units (AU) (right panel).  
(c) Quantitative real-time PCR analysis of Mki67 in primary hepatocytes. Symbols represent 
individual animals and P values represent comparisons between 10 d versus 6 w mice using 
PANTHER over-representation test (a) and unpaired t test with Welch-correction (b) calculated with 
log2 values (c). **P < 0.005 and ****P < 0.00005. 
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7.3 Treg cells in the neonatal liver protect liver homeostasis and 
metabolic liver function  
To analyze the function of Treg cells in the liver, a mouse model of Diphtheria toxin 
receptor (DTR)-mediated Treg cell depletion was used. Treg cells were depleted by 
injecting Diphtheria toxin (DT) in Foxp3-DTReGFP mice expressing the DTR as 
well as GFP under control elements of the Foxp3 promoter (Kim, Rasmussen, and 
Rudensky 2007). Flow cytometry analysis revealed that around 95% of  
Foxp3GFP+ Treg cells were depleted in the spleen and the liver 48 hours after DT 
injection in 10 day-old as well as 6 week-old mice (Fig. 21a).  
In order to determine whether Treg cell ablation resulted in liver damage we 
measured the concentrations of the enzymes alanine-aminotransferase (ALT/GPT) 
and aspartate transaminase (AST/GOT) in the blood of neonatal mice (Fig. 21b). 
Whereas Treg cell depletion led to no differences in the AST presence in the blood, 
we detected a slight increase in the ALT concentration in the blood of DT-treated  
10 day-old mice. Additionally, Treg cell depletion in neonatal as well as adult mice 
resulted in a significant increase of cytokine and chemokine expression levels 
assessed by quantitative real-time PCR as well as microarray analysis  
(Fig. 21c, d). Analysis of DT-injected DTR negative control mice alongside the 
Foxp3-DTReGFP animals showed no elevated gene expression levels, indicating 
that DT injection itself had no effect on the hepatic gene expression (Fig. 21c).  
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Figure 21: Treg cell depletion in neonatal and adult livers. Treg cells were depleted by injecting 
Diphtheria Toxin (DT) into 10 day-old (10 d) and 6 week-old Foxp3-DTReGFP mice (DTR+) or 
C57BL/6 mice (DTR-) and analyzed after 48 h. PBS injected mice served as control mice.  
(a) Treg cell depletion efficiency measured via flow cytometry by the presence of Foxp3+ Treg cells in 
the liver and spleen of DT-treated mice. (b) Photometric analysis of alanine-aminotransferase 
(ALT/GPT) and aspartate transaminase (AST/GOT) in blood plasma of 10 d mice. (c) Quantitative 
real-time PCR analysis of Tnfa and Cxcl10 in livers of DT or PBS treated mice. (d) Heat map of 
chemokine expression assessed by RNA-based microarray analysis in liver and lung from 10 d and 
6 w DT or PBS treated mice. Genes with greatest (red) or least (blue) transcript abundance in each 
group, presented as Pearson’s correlation (row normalized; n = 3). P values represent comparisons 
between DT and PBS treated livers of 10 d or 6 w mice using unpaired t test with Welch- 
correction (b) and ordinary two-way ANOVA with Sidak´s multiple comparison test calculated with 
log2 values (c). NS, not significant; ***P < 0.0005 and ****P < 0.00005. 
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With the help of RNA-based microarray analysis we measured the effect of Treg cell 
depletion on hepatic gene expression. More than 5000 gene probes were 
differentially expressed in the neonatal liver in comparison to the significantly 
altered 80 gene probes in the liver of 6 week-old mice (Fig. 22a). Interestingly, the 
loss of Treg-mediated control had little effect on the gene expression in the lung of 
the same mice (Fig. 21d; Fig. 22b). In comparison to the liver, no differences in 
cytokine and chemokine gene expression were detected in the lung after loss of 
Treg-mediated control (Fig, 21d) and significantly less genes were differentially 
expressed in the Treg-depleted lung (Fig. 22b). These findings suggest that  
Treg cells have a critical role in the liver. 
 
Figure 22: Gene expression in neonatal livers was strongly affected after Treg cell depletion.  
Treg cells were depleted by injecting Diphtheria Toxin (DT) into 10 day-old (10 d) and 6 week-old 
Foxp3-DTReGFP mice. PBS injected mice served as control mice. The livers of theses mice were 
analyzed after 48 h. (a) Differentially expressed hepatic gene probes of DT versus PBS treated 10 
d or 6 w mice. (b) Differentially expressed gene probes of DT versus PBS treated mice in liver and 
lung of 6 w or 10 d mice. P values represent comparisons between DT and PBS treated livers or 
lungs of 10 d or 6 w mice using Chi2-test for proportions. 
 
Among the 5000 differentially expressed genes in the neonatal Treg-depleted liver, 
we observed a significantly increased expression of transcriptions factors  
(Fig. 23a, b). Interestingly, the increased gene expression of transcription factors 
(Fig. 23a, b) as well as chemokines (Fig. 21d) in the Treg-depleted liver was more 
specific for the neonatal state than for the adult state.   
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Therefore, we suggest that the effect of removing Treg-mediated control is more 
pronounced in the 10 day-old liver as compared to the adult liver. 
 
Figure 23: Expression of transcriptions factors in the livers of Treg-depleted mice. Treg cells 
were depleted by injecting Diphtheria Toxin (DT) into 10 day-old (10 d) and 6 week-old (6 w)  
Foxp3-DTReGFP mice. PBS injected mice served as control mice. The livers of these mice were 
analyzed after 48 h. Heat maps of transcriptions factor gene expression: genes with greatest (red) 
or least (blue) transcript abundance in each group, presented as Pearson’s correlation (row 
normalized; n = 3) and assessed by RNA-based microarray analysis. (a) Significantly 2-fold  
up-regulated gene expression in Treg-depleted livers of 10 d mice in comparison to livers of 10 d 
control mice. (b) Significantly 2-fold up-regulated gene expression in Treg-depleted livers of 6 w 
mice in comparison to livers of 6 w control mice.   
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To determine whether we could detect the same changes on protein level, we 
performed an unbiased quantitative proteome analysis of DT-injected and PBS-
injected neonatal and adult livers. In total we identified 4440 proteins in all groups. 
Through the direct comparison of significantly down-regulated proteins with their 
mRNA expression, we showed that in most cases protein followed mRNA 
expression (Fig. 24a).  
Since microarray array analysis demonstrated elevated hepatic gene expression in 
Treg-depleted neonatal mice, including cytokines, chemokines and several 
transcription factors (Fig. 21-23), we were interested in the protein and gene 
expression that were down-regulated after loss of Treg cells in the neonatal liver. 
Using the Gene Ontology (GO) platform, we detected that most under-represented 
hepatic proteins as well as genes at the neonatal stage were involved in metabolic 
processes such as organic acid or fatty acid metabolism (Fig. 24b, c).  
Two pathways were of particular interest. First, genes encoding proteins involved 
in the alpha amino acid metabolic pathway such as the enzymes cysteine sulfinic 
acid decarboxylase (Csad), the D-aspartate oxidase (Ddo) or arylformamidase 
(Afmid) were significantly down-regulated in the liver of 10 day-old mice without 
Treg-mediated control (Fig. 24d). The same pattern could be observed in a second 
group of genes interacting in the acyl-CoA metabolism, such as acetyl-coenzyme 
A synthetase (Acss2), different members of acyl-CoA thioesterase (Acot 3, 12, 14) 
and acyl-CoA dehydrogenase (Acadsb) (Fig. 24e).  
Taken together, these results suggest that the presence of Treg cells in the liver at 
the neonatal stage is necessary to establish liver homeostasis and proper 
metabolic liver function since Treg cell ablation in neonatal mice resulted in altered 
expression of genes involved in metabolic processes in the liver. 
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Figure 24: Treg cell depletion in neonatal livers induced changes in expression of genes 
involved in metabolic liver function. Treg cells were depleted by injecting Diphtheria Toxin (DT) 
into 10 day-old (10 d) and 6 week-old Foxp3-DTReGFP mice. The livers of the mice were analyzed 
after 48 h with microarray analysis and quantitative proteomics. PBS injected mice served as 
control mice. (a) Fold-change by P value plot of hepatic 268 gene probes identified to be 
significantly down-regulated on protein level after Treg cell depletion in 10 d mice. (b - c) Gene 
ontology (GO) analysis of (b) proteins and (c) genes significantly down-regulated in livers from DT 
versus PBS treated 10 d mice. (d - e) Fold-change by P value plot of hepatic genes with (d) the GO 
1901605 coding for the alpha amino acid metabolic process or (e) GO 0006637 coding for the acyl-
CoA metabolic process in DT versus PBS treated 10 d mice. Individual genes are highlighted. P 
values represent comparisons between DT and PBS treated 10 d mice using ordinary two-way 
Chi2-test for proportions (a, d, e) or PANTHER over-representation test (b, c).  
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7.4  Treg cells influence the circadian rhythm 
Treg cell depletion affected core-clock gene expression in the liver 
As described in the previous section, loss of Treg-mediated immune control by 
depletion of Treg cells induced strong alterations in the gene as well as protein 
expression levels in the liver (Fig. 21-24). A fold-change to fold-change 
comparison showed up-regulation of transcription factors involved in regulation of 
the circadian rhythm in both Treg-depleted livers of neonatal as well as adult mice 
(Fig. 25a). For example, the negative feedback regulators of the clock Rev-Erb-, 
Rev-Erb-, Per1, Per2, Bhlhb2 and the circadian associated repressor of 
transcription (Ciart), as well as the clock-controlled gene Dbp (albumin D-box 
binding protein) and Jun B proto-oncogene (Junb) were highly up-regulated at both 
ages (Fig. 25a, b and c). Quantitative real-time PCR analysis confirmed our 
microarray results (Fig. 25a, d). As seen before for the gene expression of 
cytokines and chemokines (Fig. 21c), analysis of DT-injected DTR negative control 
mice alongside the Foxp3-DTReGFP mice demonstrated that DT injection itself 
had no effect on the elevated hepatic expression of core-clock genes and clock-
controlled genes (Fig. 25d). The liver seemed to be in a stressed state due to the 
elevated expression levels of cytokines and chemokines (Fig. 21) and genes 
involved in the complex process of the cellular stress response such as the 
activating transcription factor 3 (Atf3) (Fig. 25b, c, d). Interestingly, the lung, 
another peripheral organ for which gene expression is known to be partly regulated 
by the circadian clock, did not show these differences in neonatal or adult mice 
(Fig. 25b, c).  
Taken together, our findings demonstrate that the loss of Treg-mediated immune 
control lead to an age-independent up-regulation of genes involved in regulation of 
the hepatic circadian clock.  
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Figure 25: Loss of Treg-mediated control induced elevated levels of core-clock gene 
expression in the liver. Treg cells were depleted by injecting Diphtheria Toxin (DT) into 10 day-old 
(10 d) and 6 week-old (6 w) Foxp3-DTReGFP mice. PBS injected mice served as control mice. The 
liver and lung of these mice were analyzed after 48 h. (a) Fold-change by fold-change plot of 
hepatic gene expression of DT versus PBS treated 10 d and 6 w mice. (b - c) Heat maps of hepatic 
gene expression in livers and lungs from DT and PBS treated 10 d and 6 w mice. Genes with 
greatest (red) or least (blue) transcript abundance in each group, presented as Pearson’s 
correlation, row normalized (n=3). (d) Quantitative real-time PCR analysis of Atf3, the core-clock 
genes Rev-Erb-and Per1 and the clock-controlled gene Dbp in livers of DT and PBS treated 
Foxp3-DTReGFP mice (DTR+) and C57BL/6 mice (DTR-) of both age groups. Symbols represent 
individual animals and P values represent comparisons between DT versus PBS treated 10 d or  
6 w mice using ordinary two-way ANOVA with Sidak´s multiple comparison test calculated with log2 
values (d). NS, not significant; ***P < 0.0005 and ****P < 0.00005.  
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Modified hepatic circadian rhythm in Treg-depleted livers 
Circadian rhythms are known to occur with a repeating period close to 24 hours 
(Scheiermann, Kunisaki, and Frenette 2013). As described in the previous section 
we observed elevated gene expression levels of circadian core-clock genes and 
clock-controlled genes in the liver 48 hours after the loss of Treg-mediated control. 
To analyze the changes in the hepatic circadian rhythm before and after the  
48 hour time point, we depleted Treg cells in 6 week-old mice over a period of  
54 hours and harvested the organs every 6 hours to cover different night and day 
periods. During this depletion kinetic we detected a constant over-expression of 
chemokines initially found to be differentially expressed at the 48 hour time point 
after Treg cell depletion (Fig 21d). Chemokines such as Cxcl10 were reproducibly 
up-regulated at every time point of the kinetic measured by RNA-based microarray 
analysis (Fig. 26a). The changes in Treg-depleted livers occurred extremely rapidly, 
as we detected an elevated chemokine expression level already after 24 hour DT 
treatment in the liver (Fig. 26a). With the help of RNA-based microarray analysis 
we were able to measure oscillation patterns of core-clock genes (Fig. 26b) and 
clock-controlled genes (Fig. 26c). The expression of the negative feedback 
regulators of the clock Rev-Erb-, Rev-Erb-, Per1, Per2, Ciart and Bhlhb2 as well 
as the clock-controlled genes Dbp and Foxo3 (insulin-phosphatidylinositol 3-
kinase-Forkhead box class O3a) were all significantly altered in Treg-depleted livers 
and showed a complete loss of rhythmicity or a change of the oscillation phase 
(Fig. 26b, c). The core-clock genes Clock and Bmal1 showed slight changes in 
Treg-depleted livers, but overall the oscillation pattern of Clock and Bmal1 were less 
affected as compared to the negative feedback regulators of the hepatic clock and 
the clock-controlled genes, whose circadian rhythms were partly or completely 
abrogated (Fig. 26b, c). To understand the impact of the changes in the hepatic 
clock, we statistically analyzed the oscillation patterns of genes with a circadian 
and non-circadian expression in Treg-deficient and Treg-sufficient livers. Therefore 
we used the established JTK_CYCLE algorithm (Hughes, Hogenesch, and 
Kornacker 2010) with false discovery rates (FDR) of 5% or 20% (Fig. 26d). We 
detected that about 25 to 30% of the genes with a circadian expression showed an 
altered oscillation pattern when Treg-mediated control was absent in the liver, 
whereas the expression pattern of genes without circadian regulation were less 
affected (around 10%) by Treg cell depletion (Fig. 26d).  
Results 
77 
 
Figure 26: Disturbed circadian gene expression in Treg-depleted livers. Treg cells were depleted 
by injecting Diphtheria Toxin (DT) in 6 week-old Foxp3-DTReGFP mice. PBS injected mice served 
as control mice. Livers were harvested 24 h (12 pm), 30 h (6 pm), 36 h (12 am), 42 h (6 am),  
48 h (12 pm) and 54 h (6 pm) after the first DT injection and the hepatic gene expression were 
assessed by RNA-based microarray analysis. (a) Heat map of chemokine expression. Genes with 
greatest (red) or least (blue) transcript abundance in each group, presented as Pearson’s 
correlation, row normalized (n=3 per group and time point). (b - c) Circadian expression kinetic of 
(b) core-clock genes and (c) clock-controlled genes in Treg-depleted liver (DT, red) or control livers 
(PBS, black). Night phase is marked in grey. (d) Circadian probes were identified using the 
JTK_CYCLE algorithm with false discovery rates (FDR) of 5% and 20%. Genes with circadian or 
non-circadian expression were tested whether DT treatment significantly changed their gene 
expression pattern.   
Results 
78 
Furthermore, gene expression appears to follow different oscillation patterns in  
Treg-depleted livers, whereby two clusters are particularly interesting. Genes with 
altered oscillation patterns seemed to follow the changed circadian expression 
pattern of the negative feedback regulators of the circadian clock Per1 or Rev-Erb-
 in Treg-depleted livers. Interestingly, these clusters of genes included other 
negative feedback regulators of the hepatic clock as well as other genes regulated 
by the circadian clock (Fig. 27 a, b; Appendix Table 12, 13).  
 
 
 
 
Figure 27: Different patterns of altered circadian gene expression in Treg-depleted livers.  
Treg cells were depleted by injecting Diphtheria Toxin (DT) in 6 week-old Foxp3-DTReGFP mice. 
PBS treated mice served as control mice. Livers were harvested 24 h (12 pm), 30 h (6 pm),  
36 h (12 am), 42 h (6 am), 48 h (12 pm) and 54 h (6 pm) after first DT injection and hepatic gene 
expression were assessed by RNA-based microarray analysis. Gene probes showing similar DT 
versus PBS regulation patterns over time as (a) Per1 and (b) Rev-Erb-α, which were assessed by 
Pearson’s correlation coefficient.  
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In a second statistical approach, the established RAIN algorithm (Thaben and 
Westermark 2014) with a FDR of 1% was used to identify and verify genes with a 
circadian expression. In accordance with the JTK_CYCLE algorithm analysis, 
oscillating genes identified by the RAIN algorithm were significantly more affected 
by the loss of Treg cells in the liver as compared to non-circadian genes (Fig. 28a). 
For example, the clock-controlled gene Junb completely lost its circadian 
expression pattern after DT treatment (Fig. 28b). Studies in rodents have shown 
that Junb expression in the SCN is induced by light and correlates with the light-
mediated phase shifts in circadian rhythm of the SCN (Beaule and Amir 1999). 
With the help of JTK_CYCLE and RAIN algorithm we detected in total more than 
400 oscillating genes showing an altered circadian expression pattern in  
Treg-depleted livers, with an overlap of 297 genes between the two approaches 
(Fig. 28c).  
 
 
 
Figure 28: RAIN algorithm identified altered circadian gene expression in Treg-depleted 
livers. Treg cells were depleted by injecting Diphtheria Toxin (DT) in 6 week-old Foxp3-DTReGFP 
mice. PBS treated mice served as control mice. Livers were harvested 24 h (12 pm), 30 h (6 pm), 
36 h (12 am), 42 h (6 am), 48 h (12 pm) and 54 h (6 pm) after first DT injection and hepatic gene 
expression were assessed by RNA-based microarray analysis. (a) Circadian probes were identified 
using RAIN algorithm with a FDR of 1%. Genes with circadian and non-circadian expression were 
tested whether DT significantly changed their gene expression pattern. (b) Circadian expression 
kinetic of the clock-controlled gene Junb in Treg-depleted (DT, red) or control (PBS, black) livers. 
Dots represent individual animals. (c) Genes with altered circadian expression calculated with 
JTK_CYCLE algorithm or RAIN algorithm. Numbers indicate probes identified with the respective 
algorithm. 
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In the previous section we described that Treg cell depletion resulted in down-
regulation of genes involved in metabolic pathways (Fig. 24b and c). Moreover, it is 
known that several metabolic pathways in the liver are under control of the hepatic 
clock (Ferrell and Chiang 2015). To determine the relationship between the altered 
expression of oscillating genes in livers without Treg cells and liver metabolism, we 
analyzed the 297 oscillating genes that show an altered oscillation pattern in  
Treg-depleted livers identified by the RAIN- and the JTK_CYCLE algorithms using 
the Gene Ontology (GO) platform. Besides the expected processes of `circadian 
rhythm´ and `circadian regulation of gene expression´, the GO analysis revealed 
additional involvement of the oscillating genes in certain metabolic processes in 
the liver (Fig. 29a). Genes involved in the acyl-CoA metabolism or alpha amino 
acid metabolism showed a down-regulated circadian expression pattern in  
Treg-depleted livers, such as the acyl-CoA thioesterase 12 (Acot12) or the 
arylformamidase Afmid (Fig. 29b, c). Interestingly, Afmid was completely disrupted 
after loss of Treg-mediated control (Fig. 29c).  
Collectively, our data indicates that Treg cells are needed to ensure normal 
circadian expression of core-clock regulators and clock-controlled genes, as well 
as to guarantee normal regulation of metabolic processes in the liver.  
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Figure 29: Treg cell depletion induced altered expression of circadian genes involved in 
metabolic processes. (a) Gene ontology (GO) analysis of the 297 RAIN- and JTK_CYCLE-
identified genes with alteration in their circadian gene expression after Treg cell depletion with 
Diphtheria Toxin in the liver of 6 week-old Foxp3-DTReGFP. PBS treated mice served as control 
mice. Livers were harvested 24 h (12 pm), 30 h (6 pm), 36 h (12 am), 42 h (6 am), 48 h (12 pm) 
and 54 h (6 pm) after first DT injection and hepatic gene expression were assessed by RNA-based 
microarray analysis. (b - c) Circadian gene expression kinetic of acyl-CoA thioesterase 12 (Acot12) 
involved in the acyl-CoA metabolism or genes (arylformamidase (Afmid); ornithine 
transcarbamylase (Otc); glutamine synthetase (Glul)) involved in the alpha amino acid metabolism 
in Treg-depleted livers (DT, red) or control livers (PBS, black). Night phase is marked in grey.  
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Hepatic circadian expression in Rag2-/- and macrophage depleted mice  
To determine the specificity of the disturbed rhythmicity and phase shift in gene 
expression of hepatic core-clock genes and clock-controlled genes to Treg cell 
depletion, we analyzed the oscillation pattern of the same genes in liver of  
Rag2-deficient mice. The complete developmental block of mature B and T cells in 
Rag2-deficient mice did not cause the same changes in circadian gene expression 
pattern of the negative feedback regulators Rev-Erb- as measured before in  
Treg-depleted livers (Fig. 30 a, b, c). The same was found for the other negative 
feedback regulators Rev-Erb-, Per1 and 2, Ciart, Bhlhb2 and the clock-controlled 
genes Dbp and Cxcl10  (Fig. 30 b, c).  
Since the permanent deficiency for mature B and T cells in Rag2-deficient mice did 
not mimic the altered oscillation pattern of livers without Treg cells (Fig. 30), we 
wanted to test another acute depletion model. DT treatment of Csfr1-DTR mice 
results in ablation of myeloid cells, including liver-resident Kupffer cells and 
monocytes, and is based on the colony stimulating factor 1 receptor (Csf1r)-
mediated expression of the DTR, which has to be first licensed by the myeloid cell 
specific LysM Cre-mediated excision of a loxP flanked Stop cassette (Schreiber et 
al. 2013). We observed an efficient depletion of F4/80+ Kupffer cells and  
Ly6Chigh monocytes in the liver after 48 hours DT injections (Fig. 31a). The same 
DT concentration as in the Treg cell depletion study was used. However, depletion 
of hepatic Kupffer cells and monocytes did not lead to significant changes in gene 
expression of the clock regulators Rev-Erb- and Per1, or clock-controlled genes 
Dbp and Cxcl10 (Fig. 31b, c). Stress-induced expression of hepatic Atf3 was 
affected by Treg cell depletion but not by ablation of hepatic macrophages and 
monocytes (Fig. 31d). The elevated expression levels of chemokines and 
cytokines induced by Treg cell depletion (Fig. 21d) was not observed in Csfr1-DTR 
mice after DT injection (Fig. 31e, f). Interestingly, in contrast to the elevated 
hepatic chemokine expression in Treg-depleted mice, we measured a slight down-
regulated expression of cytokines and chemokines such as Il15 or Ccl5 in  
DT-treated Csfr1-DTR mice (Fig. 31e, f).  
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Taken together, these findings suggest that the detected changes in hepatic  
core-clock and clock-controlled gene expression are Treg cell depletion specific. 
Neither the elimination of macrophages, the DT itself nor the apoptotic cell death 
induced by DT injection in the DTR-positive cells were able to alter the circadian 
rhythm in the liver.  
 
 
Figure 30: Development block of mature B and T cells had no influence on the hepatic 
circadian gene expression. Quantitative real-time PCR analysis of negative feedback regulators 
of the hepatic clock or clock-controlled genes. (a) Rev-Erb-α expression in livers of Treg-depleted 
mice. (b - c) Circadian gene expression of (b) negative feedback regulators of the hepatic clock and  
(c) clock-controlled genes in livers of Rag2-deficient mice. Symbols represent individual animals 
and P values represent comparisons between DT versus PBS using Two-way RM ANOVA for over 
time analysis, NS, not significant. 
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Figure 31: Loss of macrophages did not mimic Treg cell depletion induced changes in 
circadian gene expression. Csf1r DTR mice were injected with Diphtheria Toxin (DT) to deplete 
macrophages and monocytes. PBS injected mice served as control mice. (a) Flow cytometry gating 
of F4/80+ Kupffer cells (red gate) and Ly6Chigh monocytes (blue gate) in DT or PBS injected mice. 
Ly6Clow monocytes are gated in black. (b - c) Quantitative real-time PCR analysis of (b) core-clock 
genes, (c) controlled genes and (d) Atf3 in myeloid cell-depleted livers (Csf1r DTR+) and  
Treg-depleted livers (Foxp3 DTR+). (e - f) Quantitative real-time PCR analysis of (e) chemokines 
and (f) cytokines in Csf1r-DTR mice. P values represent comparisons between DT versus PBS 
using ordinary two-way ANOVA with Sidak´s multiple comparison test calculated with log2 values 
(b - d) and unpaired t test with Welch-correction calculated with log2 values (e, f). NS, not 
significant; **P < 0.005, ***P < 0.0005 and ****P < 0.00005. 
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Liver inflammation and the circadian rhythm 
Since previous findings showed that Treg cell depletion resulted in elevated levels 
of hepatic chemokines and cytokines (Fig. 21), we analyzed whether inflammatory 
mediators could induce the loss of circadian rhythmicity. We isolated primary 
hepatocytes from 6 week-old livers and cultured them for 48 hours in vitro with 
different stimuli such as TNF-, IFN-, IL-6, IL-10, TGF- or the glucocorticoid 
dexamethasone, a hormone known to be a circadian time cue for the hepatic clock 
(Scheiermann, Kunisaki, and Frenette 2013). The clock regulator Rev-Erb-α was 
one of the genes whose circadian expression was strongly disturbed in the liver of  
Treg-depleted mice (Fig. 25, Fig. 26b, Fig. 30a). However, in the culture system of 
primary hepatocytes neither dexamethasone nor any of the cytokines could mimic 
any of the changes in Rev-Erb-α expression pattern detected in Treg-depleted livers 
(Fig. 32).  
 
 
Figure 32: Cytokine or dexamethasone treatment did not result in alteration of Rev-Erb-α 
gene expression. Quantitative real-time PCR analysis of Rev-Erb-α expression in primary 
hepatocytes cultured in Williams E medium (black) and supplemented with either Dexamethasone, 
TNF-, IFN-, TGF-, IL-6 or IL-10 (green). Cells were harvested every 12 hours. Symbols 
represent individual animals and P values represent comparisons between different in vitro 
treatments using Two-way RM ANOVA for over time analysis, NS, not significant. 
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Furthermore, expression of genes showing a changed expression pattern in the 
liver of Treg-depleted mice (Fig. 25, Fig. 26), such as Atf3 and several core-clock 
and clock-controlled genes, were generally not altered in the primary hepatocytes  
(Fig. 33). However, we could observe changes of individual parameters. For 
example, IFN- treatment led to significantly increased expression of Atf3 and 
Cxcl10, as well as TGF- could efficiently induce the expression of Bhlhb2 in 
primary hepatocytes (Fig. 33b, c, e). In contrast to the observed in vivo data, we 
saw that the expression of some parameters were even reduced. For example, the 
expression levels of Dbp and Atf3 were significantly down-regulated after 
treatment with TGF- (Fig. 33c, e). Additionally, treatment with TNF- or 
dexamethasone led to a down-regulated gene expression of the clock-controlled 
gene Dbp (Fig. 33a, d, e).  
Therefore we conclude that treatment with individual effector molecules might not 
accurately mirror the complex situation observed in the in vivo model.  
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Figure 33: Gene expression of in vitro cultured primary hepatocytes. Quantitative real-time 
PCR analysis of gene expression in cultured primary hepatocytes (black line), which were 
stimulated (green line) with (a) dexamethasone, (b) IFN-, (c) TGF- or (d) TNF- Cells were 
harvested every 12 hours. Night phase (6 pm to 6 am) is marked in grey. (e) Summary table of 
stimuli induced differences in gene expression of primary hepatocytes represented with their  
P values. Red and blue indicate significant increased or decreased gene expression. P values 
represent comparisons between stimulated versus unstimulated primary hepatocytes using  
Two-way RM ANOVA for over time analysis. NS, not significant; *P < 0.05, **P < 0.005,  
***P < 0.0005 and ****P < 0.00005. 
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To determine in a mouse model whether liver inflammation triggered the observed 
alteration in the circadian rhythm, we analyzed the inflammatory liver model of  
Mdr2-deficient mice which develop chronic liver inflammation (Mauad et al. 1994; 
Pusterla et al. 2013). We analyzed the liver of six month-old Mdr2-deficient mice 
and observed clear signs of inflammation as detected by the increased expression 
levels of cytokines and chemokines (Fig. 34a). Atf3 expression was slightly  
up-regulated in Mdr2-deficient mice (Fig. 34b). However, we could not measure 
elevated gene expression levels of the clock-controlled genes Dbp, Foxo3 and 
Junb as well as the negative feedback regulators Rev-Erb- and , Per1 and 2, 
Ciart and Bhlhb2 (Fig. 34c, d). These findings indicate that the oscillation of 
hepatic genes was not modified by chronic inflammation.  
Together, these results suggest that the induction of changes in the hepatic 
circadian rhythm are Treg-specific and could not be mimicked by treatment with 
dexamethasone and individual cytokines or by chronic liver inflammation. 
Figure 34: Circadian gene expression in livers of Mdr2-/- mice. RNA-based microarray analysis 
of hepatic genes in 6 month-old Mdr2+/- or Mdr2-/- mice. (a) Heat-map and hierarchical clustering of 
hepatic chemokine expression. Genes with greatest (red) or least (blue) transcript abundance in 
each group, presented as Pearson’s correlation (row normalized). (b - d) Gene expression of  
(b) Atf3, (c) clock-controlled genes and (d) core-clock genes represented as arbitrary units (AU).  
P values represent comparisons between Mdr2+/- and Mdr2-/- mice using unpaired t test with Welch-
correction. NS, not significant; **P < 0.005. 
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Hepatic Treg cells safeguard the hepatic circadian rhythm 
Next, we wanted to analyze whether Treg cells could normalize the hepatic 
circadian rhythm. In the used Treg cell depletion model, Treg cells reappear after a 
week (Kim, Rasmussen, and Rudensky 2007). Seven days after Treg cell depletion, 
we detected that about 3% of the hepatic as well as splenic CD4+ T cell pool were 
Foxp3+ Treg cells (Fig. 35a). Therefore, about 40% of the normal hepatic Treg cell 
percentage reappeared (Fig. 35b).  
 
Figure 35: Hepatic Treg cell frequency 7 days after Treg cell depletion. Treg cells were depleted 
by injecting Diphtheria Toxin (DT) into 6 week-old Foxp3-DTReGFP mice and analyzed after 7 days  
(7 d). PBS injected mice served as control mice. (a) Treg cell depletion efficacy measured via flow 
cytometry by the presence of Foxp3+ Treg cells in the liver and spleen of DT-treated mice.  
(b) Quantification of Treg cell frequencies after 48 h and 7 d DT treatment. Symbols represent 
individual animals and P values represent comparisons between DT versus PBS treated mice using 
Wilcoxon Test. ***P < 0.0005and ****P < 0.00005. 
Interestingly, we could not detect elevated expression levels of the clock regulators 
Rev-Erb- and Per1, the clock-controlled genes Dbp and Foxo3 or the stress-
induced gene Atf3 seven days after Treg cell depletion. The expression of these 
genes that initially showed a significant increase 48 hours after Treg cell depletion 
(Fig. 25) went back to normal 7 days after DT treatment (Fig. 36a, b, c). 
Interestingly, signs of liver damage could be observed 7 days after Treg cell 
depletion as measured by the significant increased concentration of ALT in the 
blood of the mice (Fig. 37a). In addition, the liver still showed clear signs of 
inflammation as measured by up-regulated levels of pro-inflammatory mediators 
such as Tnfa, Ifng, Il1b, Ccl5 and Ccl2 (Fig. 37b, c).  
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Taken together, our data support the idea that Treg cells function as safeguards of 
the circadian rhythm in the liver. Hepatic Treg cells are able to regain control over 
the disturbed and imbalanced circadian rhythm. Moreover, these findings suggest 
that protection of the hepatic circadian rhythm and the anti-inflammatory properties 
of hepatic Treg cells may not necessarily be performed in a simultaneous manner.   
 
Figure 36: Normalized circadian gene expression after return of Treg cells in the liver.  
Treg cells were depleted by injecting Diphtheria Toxin (DT) into 6 week-old Foxp3-DTReGFP mice 
and analyzed after 7 days (7 d). PBS injected mice served as control mice. (a - c) Quantitative real-
time PCR analysis of (a) core-clock genes, (b) clock-controlled genes and (c) Atf3. Symbols 
represent individual animals and P values represent comparisons between DT versus PBS treated 
mice using unpaired ordinary two-way ANOVA with Sidak´s multiple comparison test calculated 
with log2 values. NS, not significant; **P < 0.005, ***P < 0.0005 and ****P < 0.00005. 
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Figure 37: Liver inflammation after return of hepatic Treg cells. Treg cells were depleted by 
injecting Diphtheria Toxin (DT) into 6 week-old Foxp3-DTReGFP mice and analyzed after 7 days  
(7 d). (a) Photometric analysis of alanine-aminotransferase (ALT/GPT) and aspartate transaminase 
(AST/GOT) in blood plasma. (b - c) Quantitative real-time PCR analysis of (b) cytokines and  
(c) chemokines. Symbols represent individual animals and P values represent comparisons 
between DT versus PBS treated mice using t test with Welch-correction (a) calculated with log2 
values (b - c). NS, not significant; *P < 0.05 and ***P < 0.0005. 
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8 Discussion 
This thesis investigated the function and phenotype of Treg cells in the murine liver. 
We described a new function of hepatic Treg cells to safeguard the hepatic 
circadian rhythm. At the same time, Treg cells play an important role in securing the 
expression of genes involved in liver metabolism, which are known to be partly 
controlled by the circadian rhythm. Furthermore, we identified a distinct phase 
during neonatal liver development, which is characterized by the functional 
immaturity of the liver, strongly proliferating hepatocytes and a low-grade 
inflammatory liver environment. This phase coincided with an accumulation of 
proliferating Treg cells in the liver of neonatal mice.  
 
 
8.1 The neonatal liver 
Through the strategic location at a crossroad of the systemic circulation, the liver is 
able to carry out its function in lipid metabolism, degradation of toxic products as 
well as carbohydrate and protein generation (Crispe 2003). Published studies have 
reported that the neonatal liver undergoes functional maturation to meet the 
metabolic demands previously shared with the placenta by highly expressing 
genes involved in metabolism, mediating lipid oxidation, sulfation and 
dicarboxylate transport (Kelley-Loughnane et al. 2002). We propose that the 
around 10 day-old liver is undergoing maturation to achieve the full metabolic and 
functional demands of an adult liver, since we detected a special hepatic 
environment with a high proliferation activity of hepatocytes in the liver of neonatal 
mice.  
On the one hand, the neonatal liver showed an increased inflammatory hepatic 
environment with up-regulated expression levels of cytokines, chemokines, as well 
as the immune-related genes S100a8 and S100a9.  
On the other hand, distinct gene families involved in liver metabolism were under-
represented in neonatal livers in comparison to adult livers, indicating the immature 
state of the liver. For example, aldehyde dehydrogenases, known to be highly 
concentrated in the liver and responsible for the oxidation of aldehydes to 
carboxylic acids, were less expressed in neonatal livers (Koppaka et al. 2012). 
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Additionally almost all members of the Cyp family were under-represented in the  
10 day-old liver in comparison to the adult liver. Bilirubin, the end product of heme 
catabolism, has been identified as the first endogenous substrate for Cyp2a5, 
whose gene was significantly lower expressed in neonatal livers as compared to 
adult livers. Cyp2a5 is normally induced by exposure to chemical hepatoxins, 
nuclear receptor ligands, metals or by liver injury and has an important role in 
bilirubin clearance mechanisms as well as the resulting cytoprotection against 
bilirubin hepatotoxicity (Abu-Bakar et al. 2011; Camus-Randon et al. 1996; Kim et 
al. 2013). Another under-represented Cyp family member was the oxysterol  
7-hydroxylase encoded by the Cyp7a1 gene, involved in the general bile acid 
synthesis pathway (Li-Hawkins et al. 2000). Furthermore, several Mup genes 
followed the described under-represented expression pattern in neonatal livers. 
Mups are unique members of the lipocalin superfamily and serve as chemical 
signals to regulate metabolic pathways. Especially the low expression of Mup1 is 
interesting, since Mup1 has been described to be involved in the regulation of the 
hepatic gluconeogenic and lipogenic programs (Zhou, Jiang, and Rui 2009). 
 
 
8.2 Neonatal hepatic Treg cells 
Besides its important role in the metabolism of glucose, bile, bilirubin and other 
nutrients, the liver can be considered as an immune-privileged organ. Less is 
known about the development of liver-resident Treg cells, especially in the early 
postnatal phase. In general, the T cell populations of neonatal mice develop from 
very few T lymphocytes from day 1 to day 15 after birth (Garcia et al. 2000).  
Treg cell development is slightly delayed relative to conventional T cells during 
ontogeny (Fontenot et al. 2005). We observed a strong proliferation and 
accumulation of Treg cells in the liver of 10 day-old mice. It is described that 
hepatocytes are able to induce Foxp3+ Treg cells within a CD4+ T cell population via 
the Notch signaling pathway in vitro (Burghardt et al. 2014). However, epigenetic 
analysis of the DNA methylation status of the Treg-specific demethylated region, 
located in the CNS2 of the Foxp3 gene, and flow-cytometry staining of the 
transcription factor Helios and the cell surface transmembrane glycoprotein Nrp1 
Discussion 
94 
revealed that the numerous Treg cells observed in the liver of neonatal mice were 
thymus-derived and not peripheral induced Treg cells.  
RNA-based microarray analysis further emphasized the differences between 
hepatic Treg cells in neonatal and adult mice. Treg cells in the neonatal liver highly  
up-regulated the anti-inflammatory cytokine Il-10 and the generally liver-
synthesized glycoprotein Ahsg (Fetuin-a). The hepatokine Ahsg can act as an  
anti-inflammatory cytokine similar to IL-10, shows anti-fibrotic activity and is 
increased express in inflamed livers (Stefan and Haring 2013; Bilgir et al. 2012; Li 
et al. 2011). One could speculate that Ahsg may have the same regulatory function 
as IL-10 in neonatal Treg cells to maintain homeostasis in the neonatal liver.  
In addition, neonatal hepatic Treg cells seem to be more activated than their 
counterparts in the adult liver, as seen by the elevated expression level of the 
transmembrane glycoprotein CD44, known to be involved in T cell activation and 
memory (Dutton, Bradley, and Swain 1998; Baaten et al. 2010), and the strongly  
up-regulated gene expression of Nkg7, which is expressed on activated Treg cells 
under the control of Foxp3 (Sugimoto et al. 2006; Turman et al. 1993). Two 
observations further underline the strong proliferation of the neonatal hepatic  
Treg cells. First, the neonatal Treg cells strongly expressed the co-stimulatory gene 
Tnfrsf9, known to be involved in regulation of T cell proliferation and IL-2 secretion 
(Watts 2005). Second, gene ontology analysis revealed that plenty of the up-
regulated genes were involved in DNA replication. 
Moreover, the activated and proliferating Treg cells in the neonatal liver strongly 
expressed the adhesion protein CD11a (LFAT) on their surface. CD11a, 
expressed on activated T cells, has been shown to play a critical role in mediating 
the homing of T cells to lymphoid and non-lymphoid tissue by interaction with the 
intercellular adhesion molecule 1 (Icam-1) and additionally functions as a  
co-stimulatory molecule for T cell activation (Kandula and Abraham 2004; 
Koboziev et al. 2012). In the liver, lymphocyte recruitment is largely independent of 
selectins, required for lymphocyte rolling in peripheral vasculature (Wong et al. 
1997). While this may still be true for neutrophils, CD4+ T cells are mainly using 
integrins, such as CD11a and Vap-1 to adhere with the liver sinusoids (Crispe 
2003; Bonder et al. 2005). Therefore, the interaction of CD11a with the numerous 
Icam-1 and Icam-2 molecules on LSECs may play a role in the recruitment of 
activated rather than resting Treg cells in the liver of neonatal mice, since CD11a 
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additionally functions as a co-stimulatory molecule for T cell activation (Kandula 
and Abraham 2004; Koboziev et al. 2012). Furthermore, these neonatal Treg cells 
up-regulated the chemokine receptor Cxcr3, known to be express on activated  
T cells and bind to the Cxc chemokines Cxcl9 (MIG) and Cxcl10 (IP-10) to recruit  
T cells and NK cells into tissues (Luster 2002). Therefore, we suggest that the 
process of Treg cell recruitment may be stronger in the neonatal liver as compared 
to the adult liver, especially due to the increased expression of chemokines in the 
neonatal liver tissue, such as the T cell and other lymphocyte chemoattractants 
Ccl5, Ccl4, Ccl2 and Cxcl10.  
 
8.3 Where does the enlarged Treg cell population in the liver of 
neonatal mice come from?  
The accumulation of Treg cells in the neonatal liver came along with an inflamed 
liver environment. One could speculate that this is induced by the first settlement 
of lymphocytes in the liver. It is described that T cell seeding of peripheral organs 
continues during the neonatal period (Garcia et al. 2000). However, only hepatic 
Treg cells and no other hepatic lymphocytes including Tconv cells, NK cells,  
Kupffer cells and monocytes showed strong accumulation in the liver tissue. 
Furthermore, despite the block of mature B cells and T cells in neonatal livers of 
Rag2-/- mice, we still observed the same inflammatory hepatic environment as 
detected in neonatal wildtype mice. Therefore, the inflammatory liver tissue seems 
not to be induced by the first settlement of lymphocytes in the liver and is also not 
induced by the accumulation of Treg cells in the neonatal liver.  
Previously, a study described that TLR/MyD88-mediated responses to microbial 
colonization in the intestine enhance the production of TGF-β1, which triggers the 
increase of Treg numbers in neonatal livers (Maria, English, and Gorham 2014). 
The gut-liver axis plays an important role in modulating the hepatic immune system 
as the liver receives blood from the portal vein from the gut. Thereby a high 
concentration of non-pathogen associated antigens such as food, and bacterial 
antigens reach the liver. To handle the high amount of these antigens, the liver 
uses a variety of mechanisms, involving the production of IL-10, Kupffer cells, as 
well as Treg cells (Erhardt et al. 2007). However, we detected the same 
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accumulation of hepatic Treg cells alongside the highly inflamed liver environment 
in neonatal mice deficient for Tlr4 or the Toll-like receptor pathway adapter 
molecules MyD88 and Trif. Therefore, bacterial antigens, such as 
lipopolysaccharide of Gram-negative bacteria which is recognized by the Tlr4, 
appear not to be responsible for the induction and expansion of the neonatal 
hepatic Treg cell pool. 
We speculate that the increased and strongly proliferating Treg cell population in 
the neonatal liver could have two other reasons. 
First, the strong proliferation and accumulation of hepatic Treg cells could represent 
the early wave of Aire-dependent Treg cells that the Mathis-Benoist group has 
recently described (Yang et al. 2015). This early wave of Treg cells may seed the 
liver with long term liver-resident Treg cells, which are described to be able to stably 
persist in adult mice and show distinct functional and phenotypic properties, such 
as higher activation and proliferation as compared to later in life generated  
Treg cells (Yang et al. 2015). Indeed, besides the detection of the high proliferation 
capacity and activation of neonatal hepatic Treg cell, we detected that the hepatic 
Treg cell proliferation is an antigen-driven TCR-dependent process, as we saw an 
elevated proportion of Nr4a1 positive Treg cell in neonatal livers. Nr4a1 expression 
is described in several studies to monitor TCR activation in T cells (Moran et al. 
2011).  
Second, the liver is in a stressed condition resulting from its metabolic immaturity 
and inflammatory environment. Therefore, the liver acutely recruits and fosters 
proliferation of Treg cells. This Treg cell wave would be transient until the liver fully 
matures. In general, the neonatal environment is described as functionally 
lymphopenic, since CD4 T cells transferred into neonatal mice undergo similar 
proliferation compared to cells transferred into lymphopenic environments in adult 
mice (Min et al. 2003; Adkins, Leclerc, and Marshall-Clarke 2004). Cytokines such 
as IL-15, of which we have seen elevated levels in neonatal livers, are key players 
in such homeostatic proliferation (Cookson and Reen 2003). Increased 
accumulation of highly proliferating Treg cells by day 10 was only detectable in the 
liver and not in other peripheral organs, such as spleen and lung. Therefore, we 
could speculate that besides the stressed state of the liver and their immaturity, the 
neonatal liver has a kind of Treg-specific lymphopenic environment, which results in 
the accumulation of strongly proliferating hepatic Treg cells.  
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However, it is not clear whether these two hypotheses of the first wave of Aire-
dependent Treg cells and the stressed and immature liver condition are truly two 
independent events that might even respond to different antigens. The molecular 
mechanisms that drive Treg cell accumulation in neonatal liver are not yet 
understood.  
 
8.4  Hepatic Treg cell depletion 
Neonatal livers seem to be more dependent on a functional hepatic Treg cell 
compartment in comparison to adult livers, as seen by the slight increase of the 
liver damage-indicating enzyme alanine-aminotransferase and the significant 
altered expression of thousands of transcripts after Treg cell removal. These 
changes in the transcriptome translated into differences in protein expression 
affected many metabolic pathways. For example, the majority of genes belonging 
to the alpha amino acid metabolism, such as Afmid, were down-regulated after 
ablation of Treg cells in the neonatal liver. This arylformamidase is crucial for the 
tryptophan metabolisms by hydrolyzing N-formyl-L-kynurenine to L-kynurenine 
(Hugill et al. 2015). A study using Afmid knockout mice showed that deficiency of 
this enzyme results in impaired glucose tolerance (Hugill et al. 2015). Most of the 
genes involved in the acyl-CoA metabolism, including acetyl-coenzyme A 
synthetase and different members of acyl-CoA thioesterases, were additionally 
down-regulated in the Treg-deficient neonatal liver. These genes are critical for 
different physiological processes such as fatty acid and cholesterol synthesis or 
lipid biosynthesis (Loikkanen et al. 2002; Horibata et al. 2013).  
Based on these data, we propose that Treg cells play an important role in regulating 
the expression of genes involved in metabolic processes in the liver, especially 
during maturation in the neonatal phase. Since Treg cell ablation in neonatal mice 
resulted in altered expression of genes involved in metabolic processes in the liver, 
which could severely affect the ability of the neonatal liver to perform its function, 
we suggest that the neonatal liver requires Treg cells to establish liver homeostasis 
and proper metabolic liver function.  
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Interestingly, gene expression chances induced by Treg cell depletion were 
significantly more pronounced in liver tissue in comparison to lung tissue of both 
age groups. One could speculate that the neonatal liver is more vulnerable due to 
the intrinsic stress of being functionally underdeveloped and immature. 
 
 
8.5  Removal of Treg cells affects the circadian rhythm 
We detected an increased expression of core-clock genes in livers from  
Treg-depleted mice both at 10 days and 6 weeks of age. These genes included  
well-known negative clock regulators such as Per1 and Rev-Erb-, as well as the 
newly described inhibitors of the clock machinery such Ciart and the basic  
helix-loop-helix transcription factor Bhlhb2 (Dec1). Ciart and Bhlhb2 contribute to 
the transcriptional feedback loop by modifying Clock/Bmal1 activity as 
transcriptional repressors in addition to the clock repressors Cry and Per (Annayev 
et al. 2014; Scheiermann, Kunisaki, and Frenette 2013). Furthermore, Treg cell 
removal induced the up-regulation of clock-controlled genes such as Dbp, whose 
circadian expression is driven directly by components of the molecular clock. 
Therefore, Dbp is activated by the Clock/Bmal1 heterodimer and repressed by the 
clock repressors Cry and Per (Ripperger et al. 2000). 
To further study the general impact of Treg cell depletion on hepatic circadian gene 
expression, we analyzed the oscillation patterns of hepatic expressed genes over 
a distinct time period. We used 6 week-old mice due to the simpler handling 
compared to neonatal mice. Treg cell depletion led to a differential expression of 
about 25 - 30% of all oscillating genes in the liver, including elevated expression or 
partly loss of rhythmicity of core-clock genes as well as clock-controlled genes. In 
total, the circadian expression of more than 400 genes was affected. An interesting 
example is Foxo3, one of the more strongly altered clock-controlled genes in  
Treg-depleted livers. Foxo3 is known to play a role in regulating the hepatic clock 
alongside insulin and is therefore critical for the regulation of gluconeogenesis and 
lipid metabolism (Chaves et al. 2014; Zhou et al. 2014). In general, metabolic and 
circadian processes are known to be tightly linked in the liver, as high-fat diet 
(HFD) in mice led to widespread remodeling of the hepatic clock and thereby 
reorganized liver metabolic pathways (Eckel-Mahan et al. 2013). Other studies 
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have shown that the general repressors of the core-clock machinery and other 
components of the principal feedback loop drive the coordination of circadian 
rhythm and metabolism in peripheral tissues. For example, dual depletion of  
Rev-Erb- and  in mice results in disrupted circadian expression of core-clock 
genes and lipid homeostatic gene networks in liver, skeletal muscle and adipose 
tissue (Solt et al. 2012; Cho et al. 2012; Zhang et al. 2015). Moreover, Rev-Erb- 
and  as well as Bhlhb2 and Dbp are direct regulators of the circadian oscillation of 
Cyp7a, involved in generation of bile acid (Li-Hawkins et al. 2000; Noshiro et al. 
2007).  
Gene ontology analysis helped us to determine whether the changes in circadian 
expressed genes were linked to metabolic pathways. Indeed, the circadian 
expressed genes, showing altered hepatic gene expression after Treg cell removal, 
were partly involved in metabolic processes. Interestingly, within these genes were 
members belonging to the alpha amino acid metabolism and the acyl-CoA 
metabolism. One of the strongest examples was the acyl-CoA thioesterase 12  
(Acot 12), which was significantly down-regulated after Treg cell depletion. 
Expression of Acot12 is under control of Dbp and other clock-controlled  
PAR domain basic leucine zipper (PAR bZip) proteins, resulting in cyclic release of 
fatty acids from thioesters (Gachon et al. 2011). Therefore, we could partly link 
altered circadian expression in Treg-depleted mice to the modified expression of 
genes involved in liver metabolism, such as gluconeogenesis and lipid metabolism. 
Consistent with the previously described Treg cell function to establish liver 
homeostasis and proper metabolic liver function in neonatal mice, our data 
suggest that Treg cells have an unrecognized function to secure the regulation of 
the hepatic circadian rhythm and closely linked metabolic pathways (Fig. 38). 
However, the molecular mechanisms by which loss of Treg cells affect the circadian 
clock in the liver are not known. Further research to clarify the complex 
mechanisms will provide new insights into the pathogenesis of clock-induced 
pathologies, such as obesity, metabolic syndrome, nonalcoholic fatty liver disease 
and liver cancer (Turek et al. 2005; Sookoian et al. 2007; Taniguchi et al. 2009). 
Besides the liver, peripheral clocks have been identified in heart (Storch et al. 
2002), pancreas (Dibner and Schibler 2015), white adipose tissue (Kohsaka et al. 
2007) and lung (Gibbs et al. 2009). Circadian rhythm in the lung tissue has been 
described to be reorganized through inflammation provoked by lung injury or 
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endotoxin treatment (Haspel et al. 2014; Gibbs et al. 2009). We detected no 
significant changes of core-clock and clock-controlled gene expression in the lung 
after Treg cell depletion. Therefore, our data suggest a local liver-intrinsic failure of 
clock regulation and a specific function of hepatic Treg cells.  
 
 
 
Figure 38: Treg cells safeguard the circadian rhythm in the liver tissue. Loss of Treg-mediating 
liver control leads to a disrupted circadian rhythmicity with altered expression pattern of the clock 
machinery in the liver of mice. Since circadian rhythm and regulation of liver metabolism pathways 
are closely linked, changes in the hepatic circadian rhythm induce alteration in liver metabolism. 
 
 
8.6 Hepatic macrophages, liver inflammation and the circadian 
rhythm 
To determine whether the depletion of lymphocytes other than Treg cells or the 
increased cell death in the liver due to DT injection could induce similar changes to 
the hepatic circadian rhythm, we depleted Kupffer cells in the liver using Csfr1-
DTR mice. In this acute depletion model, DT injection leads to ablation of 
macrophages and monocytes (Schreiber et al. 2013). In case the increased cell 
death of lymphocytes in the liver may trigger the changes of the hepatic circadian 
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rhythm, we should have observed the same or stronger disturbed hepatic circadian 
rhythm in DT-injected Csfr1-DTR mice, since Kupffer cells represent a major 
immune cell population in the liver and represent around 35% of the non-
parenchymal cells in the liver (Crispe 2003). In contrast, only 10% of the whole 
hepatic CD4 T cell population are Treg cells, which at least are 10-times fewer cells 
compared to the number of Kupffer cells. Neither the loss of Kupffer cells nor the 
increased apoptosis of immune cells in the liver provoke the same alteration of 
circadian gene expression, observed previously in Treg-depleted liver. In addition, 
DT injection itself induced no alteration in the circadian gene expression of 
components of the hepatic clock machinery of DTR negative control mice. Based 
on these findings, we suggest a central role for Treg cells in protecting the hepatic 
clock.   
Interestingly, Kupffer cell depletion did not result in liver inflammation or induction 
of the stress-inducible transcription factor Atf3 as observed before in Treg-depleted 
mice. Atf3 belongs to the Atf/Creb family of transcription factors and is greatly 
increased when the cells are exposed to stress signals as injuries, toxins, serum 
factors or cytokines (Hai et al. 1999). In DT-injected Csfr1-DTR mice, we observed 
a rather down-regulation of cytokines and chemokines, including Il-15, Tgfb and 
Ccl5. In contrast, Treg cell removal caused increased inflammation and stressed 
liver tissue as seen by the up-regulation of the stress-inducible gene Atf3 and 
several cytokines and chemokines, such as the Cxcl10 and Tnfa. Cxcl10 (IP-10) 
has been described to correlate with liver injury, but at the same time has 
hepatoprotective effects (Bone-Larson et al. 2001). In general, cytokines have 
been reported to affect the circadian clock (Lopez et al. 2014; Hashiramoto et al. 
2010; Kon et al. 2008). Particularly, TNF- and IL-1 can inhibit the ability of 
Bmal1/Clock to induce activation of E-box-dependent genes in the 
suprachiasmatic nucleus and liver (Cavadini et al. 2007).  
To investigate to which extent liver inflammation plays a role in modulation of 
hepatic circadian expression, we used the Mdr2-/- mice model. The multi-drug 
resistance (Mdr2) protein in the canalicular membrane of the bile duct functions as 
an ABC transporter to transport biliary phospholipids into bile (Pikarsky et al. 
2004). The lack of biliary phospholipids in the bile of Mdr2-/- mice results in toxic 
bile acid-induced bile duct damage, which finally leads to inflammation-induced 
hepatocellular cancer by around 12 - 16 month of age (Mauad et al. 1994; 
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Katzenellenbogen et al. 2007). Liver inflammation is already induced in the first 
weeks of life through increased levels of pro-inflammatory cytokines, such as  
TNF-α and IL-6, as well as NF-κB-induced chemokines and recruitment of immune 
cells into the liver (Fickert et al. 2004; Pikarsky et al. 2004). Despite of the high 
levels of chemokines and the elevated expression of Atf3, we could not detect a 
significant increase of clock inhibitors or clock-controlled genes in livers of  
6 month-old Mdr2-/- mice, which we observed before in Treg-depleted mice. 
Furthermore, in vitro treatment of primary hepatocytes with different cytokines or 
the glucocorticoid dexamethasone, a key hormone known to be a circadian time 
cue for the hepatic clock (Oishi et al. 2005; Scheiermann, Kunisaki, and Frenette 
2013), did also not induce the same changes in the circadian expression as 
observed before in Treg-depleted mice. For example, neither dexamethasone nor 
any of the tested cytokines were able to modify the expression of the Bmal1 
regulator Rev-Erb- (Zhang et al. 2015). In Treg-depleted mice, Rev-Erb- 
expression was severely increased early on and its oscillation phase was 
disturbed. Some cytokines could only modify individual parameters in vitro. For 
example, TGF- treatment led to a significantly increased expression of Bhlhb2 in 
primary hepatocytes, supported by the finding that TGF- signaling can reset the 
circadian clock, independently of Per induction, through rapid induction of Bhlhb2 
transcripts (Kon et al. 2008).  
Seven days after DT treatment, Treg cells were reappearing in the liver and Treg cell 
numbers were back to about 30 - 40% of normal. At that point, the initially 
disturbed circadian gene expression as well as the stress-induced Atf3 expression 
had normalized despite of the still existing inflammation in the liver tissue and the 
high level of the liver-damage enzyme ALT in the blood.  
Although the inflammatory liver environment could be directly caused by the 
deficiency in immune regulation due to the lack of Treg cells, our data suggest that 
Treg-independent liver inflammation, assessed by elevated levels of several 
cytokines and chemokines, is not sufficient to induce changes in the circadian 
rhythm. An alternative explanation for the increased hepatic inflammation could be 
that some of these factors are elevated due to the dysregulated circadian rhythm in 
the liver of Treg-depleted mice. Peripheral clocks are known to regulate several 
physiological processes, including immune functions in peripheral tissues 
(Scheiermann, Kunisaki, and Frenette 2013). For example, the core-clock 
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machinery controls production and release of different cytokines such as IL-1,  
IL-6, IFN-, TGF- and TNF-as well as the innate immune response by NK cells, 
monocytes and macrophages (Arjona and Sarkar 2006; Depres-Brummer et al. 
1997; Dimitrov et al. 2009; Kon et al. 2008; Keller et al. 2009; Ando et al. 2011; 
Bollinger et al. 2011; Hayashi, Shimba, and Tezuka 2007). Moreover, certain 
adaptive immune cells are dependent on the circadian clock. TH17 cell 
differentiation and proliferation has been described to be regulated by the circadian 
clock (Fortier et al. 2011; Yu et al. 2013). However, only cytokines have the 
reciprocal function to affect the circadian clock (Lopez et al. 2014; Hashiramoto et 
al. 2010; Kon et al. 2008). Our data now identifies Treg cells as a central cellular 
player in safeguarding the hepatic clock by stabilizing components of the core-
clock machinery, especially the negative core-clock regulators.  
 
8.7 Conclusion and perspectives 
In principle, Treg cells have two functional tasks. Besides the well-studied function 
to establish and maintain immune tolerance and immune homeostasis, tissue-
specialized Treg cells have the ability to perform non-classical functions in adult 
tissues, such as controlling metabolic parameter in the abdominal adipose tissue 
(Feuerer, Herrero, et al. 2009; Cipolletta et al. 2012). The results of this thesis 
demonstrate that Treg cells in the liver can be assigned to these tissue-specialized 
Treg cells. The well-described Treg cell population in the visceral adipose tissue 
(Feuerer, Herrero, et al. 2009; Cipolletta et al. 2012), injured muscle tissue (Burzyn 
et al. 2013) and virus-infected lung tissue (Arpaia et al. 2015) have one thing in 
common: they promote organismal homeostasis.  
By analyzing a special Treg cell population in the liver of neonatal mice, we 
identified a new non-classical function of Treg cells, performed at a very early 
postnatal phase. Treg cells help to establish tissue homeostasis, including for 
example establishment of proper metabolic function during neonatal development 
in still immature or stressed organs, such as demonstrated in the liver (Fig. 39).  
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Other tissue-specialized Treg cells which are associated with controlling or 
regulating metabolic functions are for example the VAT-resident Treg cells. These 
cells are able to take up fat droplets via the expression of CD36 (Feuerer et al. 
2010; Cipolletta et al. 2012; Burzyn, Benoist, and Mathis 2013). It will be of great 
interest to further understand the exact mechanism, which underlies the neonatal 
tissue protection by Treg cells, and examine which other organs are in need of the 
neonatal Treg protection. One could speculate that the gastrointestinal tract or other 
endocrine organs than the liver, such as kidney or pancreas, could be especially 
sensitive for the need of Treg protection in the neonatal tissue. 
Furthermore, by identifying a new non-classical role of Treg cells in regulating and 
safeguarding the hepatic clock, we show that immune cells can influence the 
circadian clock and partly affect the circadian clock-linked metabolism in liver 
tissue (Fig. 39), which was before only assigned for cytokines (Lopez et al. 2014; 
Hashiramoto et al. 2010; Kon et al. 2008). We are just starting to understand how 
the complex mechanism of the hepatic circadian clock is regulated by Treg cells 
and how this is linked to the liver metabolism in these mice. Further research in 
this area may provide new insights into the specific use of Treg cells or their 
products to interfere with circadian clock-induced diseases, such as the metabolic 
syndrome, nonalcoholic fatty liver, as well as liver cancer in the future. 
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Figure 39: Identification of two new non-classical functions of Treg cells in the liver tissue. 
Left side: Treg cells help to establish liver tissue homeostasis by helping the liver to develop from a 
stressed and immature state to a full developed mature organ. During this neonatal and immature 
phase, the immature liver is in a transition state, characterized by highly proliferating hepatocytes 
and under-represented cell clusters, partly involved in metabolic function. Right side: Treg cells 
secure the hepatic clock to regulate circadian expression in the liver, since loss of  
Treg-mediating liver control leads to a disrupted circadian rhythmicity. 
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Table 11: Comparison of Cyp proteins expressed in the liver of neonatal 
versus adult mice assessed by quantitative mass spectrometry analysis 
Cyp 
family 
ratio 10 d vs. 
6 w (log2) 
Cyp3a16 2.673902854 
Cyp8b1 0.916744235 
Cyp2b10 0.87522133 
Cyp2e1 0.850513161 
Cyp2c68 0.53333506 
Cyp20a1 0.195852667 
Cyp2a22 0.154792124 
Cyp2a12 -0.051992553 
Cyp2j6 -0.079158093 
Cyp4f13 -0.214579863 
Cyp3a11 -0.263317076 
Cyp17a1 -0.27450794 
Cyp39a1 -0.360867147 
Cyp2b9 -0.433282307 
Cyp3a41a -0.442877703 
Cyp2d26 -0.509703585 
Cyp3a13 -0.56086937 
Cyp2c70 -0.605611663 
Cyp4v3 -0.625837743 
Cyp3a25 -0.627110026 
Cyp2c40 -0.807309813 
Cyp2c44 -0.817228558 
Cyp4f15 -0.875600994 
Cyp2j5 -0.887598566 
Cyp2d22 -1.09655644 
Cyp4a14 -1.098618187 
Cyp2c69 -1.118264309 
Cyp4b1 -1.262737809 
Cyp2c39 -1.311468046 
Cyp2c29 -1.315866345 
Cyp2f2 -1.514013273 
Cyp1a2 -1.563276638 
Cyp2c37 -1.591945 
Cyp51a1 -1.705518188 
Cyp27a1 -1.796582324 
Cyp4a10 -1.85196221 
Cyp2c55 -1.960053735 
Cyp2d10 -2.12992269 
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Cyp7b1 -2.426508991 
Cyp2c50 -2.482782026 
Cyp2b13 -2.616427292 
Cyp2a4 -3.038459349 
Cyp2c54 -3.12188461 
Cyp2a5 -3.921219474 
 
 
 
Table 12: List of cluster of genes following the dysregulated pattern of Per1 
expression during Treg cell depletion 
Gene name Probe ID 
PER1 ILMN_2813484 
PER1 ILMN_2813487 
1110020G09RIK ILMN_1237830 
DAAM1 ILMN_1246330 
ZFP238 ILMN_2459155 
PTP4A1 ILMN_1223414 
ASGR2 ILMN_2613758 
SEMA4G ILMN_2718314 
MAGIX ILMN_2705203 
PPP1R15B ILMN_1239754 
DUSP16 ILMN_3112011 
ACO1 ILMN_1216382 
SYNPO ILMN_2422982 
ACOX1 ILMN_2771368 
PDXP ILMN_1228470 
PER2 ILMN_2987863 
TMEM150 ILMN_2653395 
BHLHB2 ILMN_1249378 
4931406C07RIK ILMN_2612325 
TMEM57 ILMN_2657921 
VPS4B ILMN_2455501 
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Table 13: List of cluster of genes following the dysregulated pattern of  
Rev-Erb-  expression during Treg cell depletion 
Gene name Probe ID 
REV-ERBA-a ILMN_2749669 
LOC100047427 ILMN_1229091 
DBP ILMN_2616226 
FAM102A ILMN_1225348 
CIART ILMN_3102736 
CIART ILMN_1236079 
CCDC85B ILMN_1220846 
PCSK4 ILMN_2629776 
CIART ILMN_3029489 
REV-ERBA-b ILMN_2798993 
CDV3 ILMN_2673894 
SLC5A6 ILMN_1225056 
PIK3AP1 ILMN_1257623 
A730054J21RIK ILMN_2447991 
CPOX ILMN_2972755 
RRP12 ILMN_2728118 
RGS16 ILMN_2600744 
LRP4 ILMN_1244134 
PER2 ILMN_2987862 
PCSK4 ILMN_1252464 
RPA2 ILMN_2597840 
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11 Abbreviations 
% Percent 
°C Degree Celsius 
µg Micro gram 
µl Micro liter 
µm Micro meter 
µM Micro Molar 
Acadsb Acyl-CoA dehydrogenase 
ACK buffer Ammonium chloride–potassium bicarbonate cell lysis buffer 
Acot  Acyl-CoA thioesterase 
Acot12 Acyl-CoA thioesterase 12  
Acss2 Acetyl-coenzyme A synthetase  
Afmid Arylformamidase 
Afp Alpha-fetoprotein 
Ahsg Alpha2-HS 
AIV Autoimmune hepatitis 
Aldh Aldehyde dehydrogenase 
ALT Alanine-aminotransferase 
APC Antigen presenting cell 
AST Aspartate transaminase 
Atf3 Activating transcription factor 3 
Birc5  Survivin 
Bmal1 Brain and muscle Arnt-like 1  
BSA Bovine serum albumin 
Abbreviations 
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Ca2+ Calcium 
cAMP Second messenger cyclic adenosine monophosphate  
CD Clusters of differentiation 
CD11a Lymphocyte function-associated antigen 1 (LFAT) 
Ciart Circadian associated repressor of transcription 
Clock Circadian locomotor output cycles kaput  
CLPs Common lymphoid progenitors  
CNS3 Conserved non-coding sequence 3 
Cry Cryptochrome 
Csad Cysteine sulfinic acid decarboxylase 
cTECs Cortical thymic epithelial cells  
CTL Cytotoxic T lymphocyte 
CTLA-4 Cytotoxic T lymphocyte associated antigen 4 
Cyp Cytochrome P450 
Dbp  Albumin D-box binding protein 
DC Dendritic cell 
Ddo D-aspartate oxidase 
DMB Human Duchenne muscular dystrophy 
DMEM Dulbecco‘s Modified Eagle‘s Medium 
DMSO Dimethyl sulfoxide 
DN cell CD4 and CD8 double-negative cell 
DNA Deoxyribonucleic acid 
DP cell CD4 and CD8 double-positive cell 
DT Diphtheria toxin 
DTR Diphteria toxin receptor 
Abbreviations 
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E-box Canonical Enhancer box  
EDTA Ethylenediaminetetraacetic acid 
EGF-R Epidermal growth factor receptor 
FACS Fluorescence activated cell sorting 
FBS Fetal bovine serum 
FC Fold change 
FDR False discovery rates 
Fen1  Flap structure-specific endonuclease 1 
FITC Fluorescein isothiocyanate 
Foxo3 Insulin-phosphatidylinositol 3-kinase-Forkhead box class 
O3a 
FOXP3 Forkhead box 3 
GFP Green fluorescent protein 
Glul Glutamine synthetase 
GO Gene Ontology 
HCC Hepatocellular cancer 
HCV Hepatitis C virus 
HEPES 4-(2-hydroxylethyl)-1-piperazineethanesulfonic acid 
HSCs Hematopoietic stem cells 
IDO Indoleamine 2, 3-dioxygenase  
IFN-γ Interferon γ 
Ig Immunoglobulin 
IL Interleukin 
IPEX Immunodysregulation polyendocrinopathy, enteropathy 
X-linked 
iTreg cell (in vitro) Induced regulatory T cell 
Junb Jun B proto-oncogene 
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LAG3 CD4 homologue lymphocyte activation gene 3  
LC-ESI-
MS/MS 
Liquid chromatography-electrospray ionization -tandem MS 
Lig1 Ligase 1  
LSECs Liver sinusoidal endothelium cells 
Mcm Members of the DNA helicase complex 
mdx Muscular dystrophy  
MHC Major histocompatibility complex 
min Minutes 
ml Milliliter 
mM Milli Molar 
MS Mass spectrometry 
mTEC Medullary thymic epithelial cell 
Mup Major urinary family 
NK cell Natural killer cell 
Nkg7 Natural killer cell protein 7 
NKT cell Natural killer T cell 
Nr4a1 Nuclear receptor 4a1 
Nrp1 Neuropilin 1 
Otc Ornithine transcarbamylase 
PBC Primary biliary cirrhosis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
Per Period  
PH Primary hepatocytes 
Ppar-g  Peroxisome proliferator-activated receptor-g  
Abbreviations 
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PRRs Pattern-recognition receptors 
pTreg cell Peripheral induced regulatory T cell 
qPCR Quantitative real-time PCR 
RNA Ribonucleic acid 
Rora Nuclear retinoid-related orphan receptor a 
Rore Ror response element 
rpm Rounds per minute 
RT Room temperature 
SCN Suprachiasmatic nucleus 
Tconv cell Conventional T cell 
TCR T cell receptor 
TGF-β Transforming growth factor β 
TH cell T helper cell 
TLR Toll-like-receptor  
Top2a  DNA topoisomerase 2-alpha 
Treg cell Regulatory T cell 
TSDR Treg-specific demethylation region   
tTreg cell Thymic derived regulatory T cell 
VAT Visceral adipose tissue  
α alpha 
β beta 
γ gamma 
δ delta 
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